NITRILE HYDRATASE VARIANT

Abstract

A nitrile hydratase variant of the present invention comprises substitution of at least one amino acid with another amino acid to improve two or more properties of nitrile hydratase by substitution of one amino acid.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a Continuation of U.S. application Ser. No. 13/128,323, filed May 9, 2011, which is a U.S. National Stage Application of PCT/JP2009/006055, filed Nov. 12, 2009, which claims priority to Japanese application number 2008-292819, filed Nov. 14, 2008, the entire contents of which are incorporated by reference herein in their entirety.

TECHNICAL FIELD

The present invention relates to a nitrile hydratase variant, a gene encoding the nitrile hydratase variant, a DNA containing the gene, a plasmid containing the gene, a transformant by means of the plasmid, and a method for producing a nitrile hydratase variant using the transformant.

BACKGROUND ART

In recent years, a nitrile hydratase has been discovered which is an enzyme having the nitrile-hydrating activity to convert a nitrile group of various compounds to an amide group by hydration, and a number of microorganism strains producing the above-mentioned enzyme have been disclosed. In order to produce an amide compound from a nitrile compound using a nitrile hydratase on an industrial scale, it is important to reduce the production costs for this enzyme in the total production costs for producing the amide compound. More specifically, it is necessary to increase the activity value in a unit weight of the preparation obtained from the enzyme production.

As a method for increasing the activity value by increasing the amount of the enzyme in the enzyme preparation, attempts have already been made to clone the gene encoding the above-mentioned enzyme for the purpose of expressing a large amount of the enzyme through genetic engineering methods.

For example, there are produced a plasmid expressing a large number of the Pseudonocardia thermophila-derived nitrile hydratase in the transformant and a transformant strain transformed with the plasmid. In addition, it has been made possible to produce a nitrile hydratase by means of these transformant strains, and to produce a corresponding amide compound by bringing the transformant strain or the nitrile hydratase obtained therefrom into contact with the nitrile compound (see Patent Document 1).

On the other hand, when high activation of enzyme molecule itself can be achieved, the activity value of the enzyme preparation can be further enhanced.

Attempts have heretofore been made to search for a nitrile hydratase variant with improved substrate specificity, enzyme stability or the like by introducing mutation into a specific amino acid residue in the amino acid sequence of the nitrile hydratase without damaging its activity (see Patent Document 2 to 4).

Furthermore, a nitrile hydratase variant derived from Rhodococcus rhodochrous has been disclosed in Patent Documents 5 and 6.

RELATED DOCUMENT

Patent Document

Patent Document 1: Japanese Patent Laid-open No. H9 (1997)-275978

Patent Document 2: Japanese Patent Laid-open No. 2004-194588

Patent Document 3: Japanese Patent Laid-open No. 2005-160403

Patent Document 4: WO 2004/056990

Patent Document 5: Japanese Patent Laid-open No. 2007-143409

Patent Document 6: Japanese Patent Laid-open No. 2008-253182

DISCLOSURE OF THE INVENTION

However, as compared to a wild nitrile hydratase disclosed in Patent Document 1, specific mutants in which both of the initial reaction rate and enzyme stability are improved have not been known. It is expected that the production costs for producing the amide compound can be reduced by improving the initial reaction rate and enzyme stability at the same time.

An object of the present invention is to provide a nitrile hydratase having high initial reaction rate and enzyme stability.

That is, the present invention is specified by matters described in below.

[1] A nitrile hydratase variant comprising substitution of at least one amino acid with another amino acid to improve two or more properties of nitrile hydratase by substitution of one or more and three or less amino acids.

[2] The nitrile hydratase variant according to [1], wherein the properties to be improved are the initial reaction rate and thermal stability.

[3] The nitrile hydratase variant according to [1] or [2], comprising an α-subunit defined in SEQ ID No: 1 in the Sequence Listing and a β-subunit defined in SEQ ID No: 2 in the Sequence Listing, and substitution of at least one amino acid with another amino acid selected from substitution sites of the amino acid consisting of the following (a) to (l):

(a) 92nd of α-subunit;

(b) 94th of α-subunit;

(c) 197th of α-subunit;

(d) 4th of β-subunit;

(e) 24th of β-subunit;

(f) 79th of β-subunit;

(g) 96th of β-subunit;

(h) 107th of β-subunit;

(i) 226th of β-subunit;

(j) 110th of β-subunit and 231st of β-subunit;

(k) 206th of β-subunit and 230th of β-subunit; and

(l) 13th of α-subunit, 27th of α-subunit and 110th of β-subunit.

[4] The nitrile hydratase variant according to [3], comprising substitution of at least one amino acid with another amino acid selected from substitution sites of the amino acid consisting of the following (m) to (u):

(m) in case of (b) or (g), 13th of α-subunit;

(n) in case of (b) or (h), 27th of α-subunit;

(o) (d) and (f);

(p) in case of (f), 230th of β-subunit;

(q) (a) and (i);

(r) in case of (i), 13th of α-subunit and 206th of β-subunit;

(s) in case of (a) and (d), 206th of β-subunit;

(t) in case of (c) and (h), 230th of β-subunit; and

(u) in case of (f), 230th of β-subunit and 231st of β-subunit.

[5] The nitrile hydratase variant according to [3], further comprising substitution of at least one amino acid with another amino acid selected from the group consisting of (a), (c), (f), (i), (h), 230th of the β-subunit and 231st of the β-subunit in case of (e) is substituted with another amino acid.

[6] The nitrile hydratase variant according to any one of [1] to [5], wherein Ile is substituted by Leu when 13th amino acid of the α-subunit is substituted,

Met is substituted by Ile when the 27th amino acid of the α-subunit is substituted,

Asp is substituted by Glu when the 92nd amino acid of the α-subunit is substituted,

Met is substituted by Ile when the 94th amino acid of the α-subunit is substituted,

Gly is substituted by Cys when the 197th amino acid of the α-subunit is substituted,

Val is substituted by Met when the 4th amino acid of the β-subunit is substituted,

Val is substituted by Ile when the 24th amino acid of the β-subunit is substituted,

His is substituted by Asn when the 79th amino acid of the β-subunit is substituted,

Gln is substituted by Arg when the 96th amino acid of the β-subunit is substituted,

Pro is substituted by Met when the 107th amino acid of the β-subunit is substituted,

Glu is substituted by Asn when the 110th amino acid of the β-subunit is substituted,

Pro is substituted by Leu when the 206th amino acid of the β-subunit is substituted,

Val is substituted by Ile when the 226th amino acid of the β-subunit is substituted,

Ala is substituted by Glu when the 230th amino acid of the β-subunit is substituted, and

Ala is substituted by Val when the 231st amino acid of the β-subunit is substituted.

[7] The nitrile hydratase variant according to any one of [3] to [6], further comprising substitution of at least one amino acid selected from substitutions of the amino acid consisting of the following (aa) to (br):

(aa) 36th Thr in the α-subunit is substituted by Met and 126th Phe in the α-subunit is substituted by Tyr;

(ab) 148th Gly in the α-subunit is substituted by Asp and 204th Val in the α-subunit is substituted by Arg;

(ac) 51st Phe in the β-subunit is substituted by Val and 108th Glu in the β-subunit is substituted by Asp;

(ad) 118th Phe in the β-subunit is substituted by Val and 200th Ala in the β-subunit is substituted by Glu;

(ae) 160th Arg in the β-subunit is substituted by Trp and 186th Leu in the β-subunit is substituted by Arg;

(af) 6th Leu in the α-subunit is substituted by Thr, 36th Thr in the α-subunit is substituted by Met, and 126th Phe in the α-subunit is substituted by Tyr;

(ag) 19th Ala in the α-subunit is substituted by Val, 71st Arg in the α-subunit is substituted by His, and 126th Phe in the α-subunit is substituted by Tyr;

(ah) 36th Thr in the α-subunit is substituted by Met, 148th Gly in the α-subunit is substituted by Asp, and 204th Val in the α-subunit is substituted by Arg;

(ai) 10th Thr in the β-subunit is substituted by Asp, 118th Phe in the β-subunit is substituted by Val, and 200th Ala in the β-subunit is substituted by Glu;

(aj) 37th Phe in the β-subunit is substituted by Leu, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(ak) 37th Phe in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(al) 41st Phe in the β-subunit is substituted by Ile, 51st Phe in the β-subunit is substituted by Val, and 108th Glu in the β-subunit is substituted by Asp;

(am) 46th Met in the β-subunit is substituted by Lys, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(an) 48th Leu in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(ao) 127th Leu in the β-subunit is substituted by Ser, 160th Arg in the β-subunit is substituted by Trp, and 186th Leu in the β-subunit is substituted by Arg;

(ap) 6th Leu in the α-subunit is substituted by Thr, 19th Ala in the α-subunit is substituted by Val, 126th Phe in the α-subunit is substituted by Tyr, 46th Met in the β-subunit is substituted by Lys, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(aq) 6th Leu in the α-subunit is substituted by Thr, 19th Ala in the α-subunit is substituted by Val, 126th Phe in the α-subunit is substituted by Tyr, 48th Leu in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(ar) 6th Leu in the α-subunit is substituted by Ala, 19th Ala in the α-subunit is substituted by Val, 126th Phe in the α-subunit is substituted by Tyr, 127th Leu in the β-subunit is substituted by Ser, 160th Arg in the β-subunit is substituted by Trp, and 186th Leu in the β-subunit is substituted by Arg;

(as) 6th Leu in the α-subunit is substituted by Thr, 36th Thr in the α-subunit is substituted by Met, 126th Phe in the α-subunit is substituted by Tyr, 10th Thr in the β-subunit is substituted by Asp, 118th Phe in the β-subunit is substituted by Val, and 200th Ala in the β-subunit is substituted by Glu;

(at) 19th Ala in the α-subunit is substituted by Val, 71st Arg in the α-subunit is substituted by His, 126th Phe in the α-subunit is substituted by Tyr, 37th Phe in the β-subunit is substituted by Leu, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(au) 19th Ala in the α-subunit is substituted by Val, 71st Arg in the α-subunit is substituted by His, 126th Phe in the α-subunit is substituted by Tyr, 37th Phe in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(av) 36th Thr in the α-subunit is substituted by Met, 148th Gly in the α-subunit is substituted by Asp, 204th Val in the α-subunit is substituted by Arg, 41st Phe in the β-subunit is substituted by Ile, 51st Phe in the β-subunit is substituted by Val, and 108th Glu in the β-subunit is substituted by Asp;

(aw) 148th Gly in the α-subunit is substituted by Asp, 204th Val in the α-subunit is substituted by Arg, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(ax) 36th Thr in the α-subunit is substituted by Gly and 188th Thr in the α-subunit is substituted by Gly;

(ay) 36th Thr in the α-subunit is substituted by Ala and 48th Asn in the α-subunit is substituted by Gln;

(az) 48th Asn in the α-subunit is substituted by Glu and 146th Arg in the β-subunit is substituted by Gly;

(ba) 36th Thr in the α-subunit is substituted by Trp and 176th Tyr in the β-subunit is substituted by Cys;

(bb) 176th Tyr in the β-subunit is substituted by Met and 217th Asp in the β-subunit is substituted by Gly;

(bc) 36th Thr in the α-subunit is substituted by Ser, and 33rd Ala in the β-subunit is substituted by Val;

(bd) 176th Tyr in the β-subunit is substituted by Ala and 217th Asp in the β-subunit is substituted by Val;

(be) 40th Thr in the β-subunit is substituted by Val and 218th Cys in the β-subunit is substituted by Met;

(bf) 33rd Ala in the β-subunit is substituted by Met and 176th Tyr in the β-subunit is substituted by Thr;

(bg) 40th Thr in the β-subunit is substituted by Leu and 217th Asp in the β-subunit is substituted by Leu;

(bh) 40th Thr in the β-subunit is substituted by Ile and 61st Ala in the β-subunit is substituted by Val;

(bi) 61st Ala in the β-subunit is substituted by Thr and 218th Cys in the β-subunit is substituted by Ser;

(bj) 112th Lys in the β-subunit is substituted by Val and 217th Asp in the β-subunit is substituted by Met;

(bk) 61st Ala in the β-subunit is substituted by Trp and 217th Asp in the β-subunit is substituted by His;

(bl) 61st Ala in the β-subunit is substituted by Leu and 112th Lys in the β-subunit is substituted by Ile;

(bm) 146th Arg in the β-subunit is substituted by Gly and 217th Asp in the β-subunit is substituted by Ser;

(bn) 171st Lys in the β-subunit is substituted by Ala and 217th Asp in the β-subunit is substituted by Thr;

(bo) 150th Ala in the β-subunit is substituted by Ser and 217th Asp in the β-subunit is substituted by Cys;

(bp) 61st Ala in the β-subunit is substituted by Gly and 150th Ala in the β-subunit is substituted by Asn;

(bq) 61st Ala in the β-subunit is substituted by Ser and 160th Arg in the β-subunit is substituted by Met; and

(br) 160th Arg in the β-subunit is substituted by Cys and 168th Thr in the β-subunit is substituted by Glu.

[8] A gene encoding the nitrile hydratase variant according to any one of [1] to [7].

[9] A gene encoding a nitrile hydratase variant having a gene encoding the α-subunit defined in SEQ ID No: 3 in the Sequence Listing and a gene encoding the β-subunit defined in SEQ ID No: 4 in the Sequence Listing, comprising substitution of at least one base selected from substitution sites of the base consisting of the following (a) to (l):

(a) 274th to 276th of the base sequence of SEQ ID No: 3;

(b) 280th to 282nd of the base sequence of SEQ ID No: 3;

(c) 589th to 591st of the base sequence of SEQ ID No: 3;

(d) 10th to 12th of the base sequence of SEQ ID No: 4;

(e) 69th to 71st of the base sequence of SEQ ID No: 4;

(f) 235th to 237th of the base sequence of SEQ ID No: 4;

(g) 286th to 288th of the base sequence of SEQ ID No: 4;

(h) 319th to 321st of the base sequence of SEQ ID No: 4;

(i) 676th to 678th of the base sequence of SEQ ID No: 4;

(j) 328th to 330th of the base sequence of SEQ ID No: 4 and 691st to 693rd of the base sequence of SEQ ID No: 4;

(k) 616th to 618th of the base sequence of SEQ ID No: 4, and 688th to 690th of the base sequence of SEQ ID No: 4; and

(l) 37th to 39th of the base sequence of SEQ ID No: 3, 79th to 81st of the base sequence of SEQ ID No: 3, and 328th to 330th of the base sequence of SEQ ID No: 4.

[10] The gene encoding a nitrile hydratase variant according to [9], further comprising substitution of at least one base selected from substitution sites of the base consisting of the following (m) to (u):

(m) in case of (b) or (g), 37th to 39th of the base sequence of SEQ ID No: 3;

(n) in case of (b) or (h), 79th to 81st of the base sequence of SEQ ID No: 3;

(o) (d) and (f);

(p) in case of (f), 688th to 690th of the base sequence of SEQ ID No: 4;

(q) (a) and (i);

(r) in case of (i), 37th to 39th of the base sequence of SEQ ID No: 3 and 616th to 618th of the base sequence of SEQ ID No: 4;

(s) in case of (a) and (d), 616th to 618th of the base sequence of SEQ ID No: 4;

(t) in case of (c) and (h), 688th to 690th of the base sequence of SEQ ID No: 4; and

(u) in case of (f), 688th to 690th of the base sequence of SEQ ID No: 4 and 691st to 693rd of the base sequence of SEQ ID No: 4.

[11] The gene encoding a nitrile hydratase variant according to [9], further comprising substitution of at least one base with another base selected from substitution sites of the base consisting of (a), (c), (f), (i), (h), 688th to 690th of the base sequence of SEQ ID No: 4, and 691st to 693rd of the base sequence of SEQ ID No: 4, in case of (e), are substituted with another base.

[12] The gene encoding a nitrile hydratase variant according to any one of [9] to [11], wherein ATC is substituted by CTC when 37th to 39th of the base sequence of SEQ ID No: 3 are substituted by another base,

ATG is substituted by ATC when 79th to 81th of the base sequence of SEQ ID No: 3 are substituted by another base,

GAC is substituted by GAG when 274th to 276th of the base sequence of SEQ ID No: 3 are substituted by another base,

ATG is substituted by ATC when 280th to 282th of the base sequence of SEQ ID No: 3 are substituted by another base,

GGC is substituted by TGC when 589th to 591th of the base sequence of SEQ ID No: 3 are substituted by another base,

GTG is substituted by ATG when 10th to 12th of the base sequence of SEQ ID No: 4 are substituted by another base,

GTC is substituted by ATC when 69th to 71th of the base sequence of SEQ ID No: 4 are substituted by another base,

CAC is substituted by AAC when 235th to 237th of the base sequence of SEQ ID No: 4 are substituted by another base,

CAG is substituted by CGT when 286th to 288th of the base sequence of SEQ ID No: 4 are substituted by another base,

CCC is substituted by ATG when 319th to 321st of the base sequence of SEQ ID No: 4 are substituted by another base,

GAG is substituted by AAC when 328th to 330th of the base sequence of SEQ ID No: 4 are substituted by another base,

CCG is substituted by CTG when 616th to 618th of the base sequence of SEQ ID No: 4 are substituted by another base,

GTC is substituted by ATC when 676th to 678th of the base sequence of SEQ ID No: 4 are substituted by another base,

GCG is substituted by GAG when 688th to 690th of the base sequence of SEQ ID No: 4 are substituted by another base, and

GCC is substituted by GTC when 691th to 693th of the base sequence of SEQ ID No: 4 are substituted by another base.

[13] The gene encoding a nitrile hydratase variant according to any one of [9] to [12], comprising substitution of at least one base selected from substitution sites of the base consisting of the following (aa) to (br), and having the nitrile hydratase activity:

(aa) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, and 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC;

(ab) 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, and 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC;

(ac) 151st to 153rd TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT;

(ad) 352nd to 354th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(ae) 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGG, and 556th to 558th CTG of the base sequence of SEQ ID No: 4 are substituted by CGG;

(af) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, and 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC;

(ag) 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 211th to 213th CGT of the base sequence of SEQ ID No: 3 are substituted by CAT, and 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC;

(ah) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, and 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC;

(ai) 28th to 30th ACC of the base sequence of SEQ ID No: 4 are substituted by GAC, 352nd to 354th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(aj) 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by CTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(ak) 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(al) 121st to 123rd TTC of the base sequence of SEQ ID No: 4 are substituted by ATC, 151st to 153rd TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT;

(am) 136th to 138th ATG of the base sequence of SEQ ID No: 4 are substituted by AAG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(an) 142nd to 144th CTG of the base sequence of SEQ ID No: 4 are substituted by GTG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(ao) 379th to 381st CTG of the base sequence of SEQ ID No: 4 are substituted by TCG, 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGG, and 556th to 558th CTG of the base sequence of SEQ ID No: 4 are substituted by CGG;

(ap) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 136th to 138th ATG of the base sequence of SEQ ID No: 4 are substituted by AAG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(aq) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 142nd to 144th CTG of the base sequence of SEQ ID No: 4 are substituted by GTG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(ar) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by GCG, 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 379th to 381st CTG of the base sequence of SEQ ID No: 4 are substituted by TCG, 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGG, and 556th to 558th CTG of the base sequence of SEQ ID No: 4 are substituted by CGG;

(as) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 28th to 30th ACC of the base sequence of SEQ ID No: 4 are substituted by GAC, 352nd to 354th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(at) 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 211th to 213th CGT of the base sequence of SEQ ID No: 3 are substituted by CAT, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by CTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(au) 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 211th to 213th CGT of the base sequence of SEQ ID No: 3 are substituted by CAT, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(av) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC, 121st to 123rd TTC of the base sequence of SEQ ID No: 4 are substituted by ATC, 151st to 153rd TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT;

(aw) 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(ax) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by GGG, and 562nd to 564th ACC of the base sequence of SEQ ID No: 3 are substituted by GGC;

(ay) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by GCG, and 142nd to 144th AAC of the base sequence of SEQ ID No: 3 are substituted by CAA;

(az) 142nd to 144th AAC of the base sequence of SEQ ID No: 3 are substituted by GAA, and 436th to 438th CGG of the base sequence of SEQ ID No: 4 are substituted by GGG;

(ba) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by TGG, and 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by TGC;

(bb) 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by ATG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by GGC;

(bc) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by TCG, and 97th to 99th GCG of the base sequence of SEQ ID No: 4 are substituted by GTG;

(bd) 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by GCC, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by GTC;

(be) 118th to 120th ACG of the base sequence of SEQ ID No: 4 are substituted by GTG, and 652nd to 654th TGC of the base sequence of SEQ ID No: 4 are substituted by ATG;

(bf) 97th to 99th GCG of the base sequence of SEQ ID No: 4 are substituted by ATG, and 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by ACC;

(bg) 118th to 120th ACG of the base sequence of SEQ ID No: 4 are substituted by CTG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by CTC;

(bh) 118th to 120th ACG of the base sequence of SEQ ID No: 4 are substituted by ATT, and 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by GTC;

(bi) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by ACG, and 652nd to 654th TGC of the base sequence of SEQ ID No: 4 are substituted by TCC;

(bj) 334th to 336th AAG of the base sequence of SEQ ID No: 4 are substituted by GTG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by ATG;

(bk) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by TGG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by CAC;

(bl) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by CTC, and 334th to 336th AAG of the base sequence of SEQ ID No: 4 are substituted by ATT;

(bm) 436th to 438th CGG of the base sequence of SEQ ID No: 4 are substituted by GGG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by AGC;

(bn) 511th to 513th AAG of the base sequence of SEQ ID No: 4 are substituted by GCG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by ACC;

(bo) 448th to 450th GCG of the base sequence of SEQ ID No: 4 are substituted by TCG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by TGT;

(bp) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by GGC, and 448th to 450th GCG of the base sequence of SEQ ID No: 4 are substituted by AAT;

(bq) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by TCG, and 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by ATG; and

(br) 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGT, and 502nd to 504th ACG of the base sequence of SEQ ID No: 4 are substituted by GAG.

[14] A linked DNA comprising further DNA containing a promoter sequence necessary for the expression of the gene in the upstream region of the 5′-terminal of the gene encoding a nitrile hydratase variant according to any one of [9] to [13], and a ribosome binding sequence contained in SEQ ID No: 7 in the downstream region of the 3′-terminal of the promoter.

[15] A plasmid comprising the DNA according to [14].

[16] A transformant obtained by transformation of a host cell using the plasmid according to [15].

[17] A method for producing a nitrile hydratase variant, comprising cultivating the transformant according to [16] in a culture medium and producing a nitrile hydratase variant based on the nitrile hydratase gene carried by the plasmid in the transformant.

According to the present invention, a nitrile hydratase composed of an α-subunit defined in SEQ ID No: 1 in the Sequence Listing and a β-subunit defined in SEQ ID No: 2 in the Sequence Listing comprises substitution of at least one amino acid with another amino acid, selected from substitution sites of the amino acid consisting of the above (a) to (l). Thus, both of the initial reaction rate and enzyme stability of the nitrile hydratase are improved, so that the activity value in a unit weight of the enzyme preparation can be increased, and at the same time the risk of enzyme deactivation due to temperature variation or the like for the industrial use can be reduced. Accordingly, the amide compound can be stably produced with a smaller amount of the enzyme, so that the production costs for producing the amide compound can be reduced.

According to the present invention, it is possible to provide a novel nitrile hydratase variant in which the initial reaction rate and enzyme stability are improved than those of the wild nitrile hydratase, and to reduce the production costs for the enzyme in the total production costs for producing the amide compound.

DESCRIPTION OF EMBODIMENTS

The above and other objects, features and advantages will be more apparent from the following description of the preferred embodiments. The present invention will be described in more detail below.

The nitrile hydratase variant of the present invention comprises substitution of at least one amino acid with another amino acid to improve two or more properties of the nitrile hydratase by the substitution of one or more three or less amino acids.

The term “properties” to be improved in the nitrile hydratase variant of the present invention refer to properties relating to the reaction itself for hydrating a nitrile group to convert it into an amide group, and enzyme stability. The term “properties” relating to the reaction itself refer to the activity of the enzyme, the substrate specificity, Vmax, Km, and the initial reaction rate. The enzyme stability includes thermal stability, stability against the substrate, and stability against the product.

The nitrile hydratase variant of the present invention preferably comprises substitution of at least one amino acid with another amino acid to improve properties of the thermophilic bacteria-derived nitrile hydratase. As the thermophilic bacteria, suitably used are those belonging to the genus Psuedonocardia. A specific example includes Psuedonocardia thermophila.

More specifically, the nitlile hydratase variant includes at least one amino acid substituted with another amino acid, selected from substitution sites of (a) to (l) as shown in Table I, in the nitrile hydratase consisting of the α-subunit defined in SEQ ID No: 1 in the Sequence Listing and the β-subunit defined in SEQ ID No: 2 in the Sequence Listing. Thus, the nitrile hydratase variant of the present invention is provided with higher initial reaction rate and enzyme stability than the wild nitrile hydratase as described in Patent Document 1.

TABLE I
			Before	After
	SEQ ID No.	No.	Substitution	Substitution
(a)	1	92	Asp	Glu
(b)	1	94	Met	Ile
(c)	1	197	Gly	Cys
(d)	2	4	Val	Met
(e)	2	24	Val	Ile
(f)	2	79	His	Asn
(g)	2	96	Gln	Arg
(h)	2	107	Pro	Met
(i)	2	226	Val	Ile
(j)	2	110	Glu	Asn
	2	231	Ala	Val
(k)	2	206	Pro	Leu
	2	230	Ala	Glu
(l)	1	13	Ile	Leu
	1	27	Met	Ile
	2	110	Glu	Asn

A plurality of substitutions of the amino acid of (a) to (l) shown in Table I may be combined, or may be combined with substitutions of the amino acid at the different sites other than (a) to (l). For example, in case of (e), at least one amino acid selected from the group consisting of (a), (c), (f), (i), (h), 230th of the β-subunit and 231st of the β-subunit may be substituted with another amino acid. Examples of substitution of the amino acid which can be combined with (a) to (l) include those in Table II.

	TABLE II
				Before	After
		SEQ ID No.	No.	Substitution	Substitution
	(m-1)	1	13	Ile	Leu
		1	94	Met	Ile
	(m-2)	1	13	Ile	Leu
		2	96	Gln	Arg
	(n-1)	1	27	Met	Ile
		1	94	Met	Ile
	(n-2)	1	27	Met	Ile
		2	107	Pro	Met
	(o)	2	4	Val	Met
		2	79	His	Asn
	(p)	2	79	His	Asn
		2	230	Ala	Glu
	(q)	1	92	Asp	Glu
		2	226	Val	Ile
	(r)	1	13	Ile	Leu
		2	206	Pro	Leu
		2	226	Val	Ile
	(s)	1	92	Asp	Glu
		2	4	Val	Met
		2	206	Pro	Leu
	(t)	1	197	Gly	Cys
		2	107	Pro	Met
		2	230	Ala	Glu
	(u)	2	79	His	Asn
		2	230	Ala	Glu
		2	231	Ala	Val
	(v)	1	92	Asp	Glu
		2	24	Val	Ile
		2	226	Val	Ile
	(w)	1	197	Gly	Cys
		2	24	Val	Ile
		2	107	Pro	Met
		2	230	Ala	Glu
	(x)	2	24	Val	Ile
		2	79	His	Asn
		2	230	Ala	Glu
		2	231	Ala	Val

The nitrile hydratase variant of the present invention may further comprise mutation in any one nitrile hydratase variant of the above (a) to (x) at sites (aa) to (br) of the amino acid of the nitrile hydratase of SEQ ID Nos: 1 and 2 as shown in Table III.

	TABLE III
				Before	After
		SEQ ID No.	No.	Substitution	Substitution
	(aa)	1	36	Thr	Met
		1	126	Phe	Tyr
	(ab)	1	148	Gly	Asp
		1	204	Val	Arg
	(ac)	2	51	Phe	Val
		2	108	Glu	Asp
	(ad)	2	118	Phe	Val
		2	200	Ala	Glu
	(ae)	2	160	Arg	Trp
		2	186	Leu	Arg
	(af)	1	6	Leu	Thr
		1	36	Thr	Met
		1	126	Phe	Tyr
	(ag)	1	19	Ala	Val
		1	71	Arg	His
		1	126	Phe	Tyr
	(ah)	1	36	Thr	Met
		1	148	Gly	Asp
		1	204	Val	Arg
	(ai)	2	10	Thr	Asp
		2	118	Phe	Val
		2	200	Ala	Glu
	(aj)	2	37	Phe	Leu
		2	108	Glu	Asp
		2	200	Ala	Glu
	(ak)	2	37	Phe	Val
		2	108	Glu	Asp
		2	200	Ala	Glu
	(al)	2	41	Phe	Ile
		2	51	Phe	Val
		2	108	Glu	Asp

TABLE III-1
(am)	2	46	Met	Lys
	2	108	Glu	Arg
	2	212	Ser	Tyr
(an)	2	48	Leu	Val
	2	108	Glu	Arg
	2	212	Ser	Tyr
(ao)	2	127	Leu	Ser
	2	160	Arg	Trp
	2	186	Leu	Arg
(ap)	1	6	Leu	Thr
	1	19	Ala	Val
	1	126	Phe	Tyr
	2	46	Met	Lys
	2	108	Glu	Arg
	2	212	Ser	Tyr
(aq)	1	6	Leu	Thr
	1	19	Ala	Val
	1	126	Phe	Tyr
	2	48	Leu	Val
	2	108	Glu	Arg
	2	212	Ser	Tyr
(ar)	1	6	Leu	Ala
	1	19	Ala	Val
	1	126	Phe	Tyr
	2	127	Leu	Ser
	2	160	Arg	Trp
	2	186	Leu	Arg
(as)	1	6	Leu	Thr
	1	36	Thr	Met
	1	126	Phe	Tyr
	2	10	Thr	Asp
	2	118	Phe	Val
	2	200	Ala	Glu

TABLE III-2
(at)	1	19	Ala	Val
	1	71	Arg	His
	1	126	Phe	Tyr
	2	37	Phe	Leu
	2	108	Glu	Asp
	2	200	Ala	Glu
(au)	1	19	Ala	Val
	1	71	Arg	His
	1	126	Phe	Tyr
	2	37	Phe	Val
	2	108	Glu	Asp
	2	200	Ala	Glu
(av)	1	36	Thr	Met
	1	148	Gly	Asp
	1	204	Val	Arg
	2	41	Phe	Ile
	2	51	Phe	Val
	2	108	Glu	Asp
(aw)	1	148	Gly	Asp
	1	204	Val	Arg
	2	108	Glu	Asp
	2	200	Ala	Glu
(ax)	1	36	Thr	Gly
	1	188	Thr	Gly
(ay)	1	36	Thr	Ala
	1	48	Asn	Gln
(az)	1	48	Asn	Glu
	2	146	Arg	Gly
(ba)	1	36	Thr	Trp
	2	176	Tyr	Cys
(bb)	2	176	Tyr	Met
	2	217	Asp	Gly
(bc)	1	36	Thr	Ser
	2	33	Ala	Val

TABLE III-3
(bd)	2	176	Tyr	Ala
	2	217	Asp	Val
(be)	2	40	Thr	Val
	2	218	Cys	Met
(bf)	2	33	Ala	Met
	2	176	Tyr	Thr
(bg)	2	40	Thr	Leu
	2	217	Asp	Leu
(bh)	2	40	Thr	Ile
	2	61	Ala	Val
(bi)	2	61	Ala	Thr
	2	218	Cys	Ser
(bj)	2	112	Lys	Val
	2	217	Asp	Met
(bk)	2	61	Ala	Trp
	2	217	Asp	His
(bl)	2	61	Ala	Leu
	2	112	Lys	Ile
(bm)	2	146	Arg	Gly
	2	217	Asp	Ser
(bn)	2	171	Lys	Ala
	2	217	Asp	Thr
(bo)	2	150	Ala	Ser
	2	217	Asp	Cys
(bp)	2	61	Ala	Gly
	2	150	Ala	Asn
(bq)	2	61	Ala	Ser
	2	160	Arg	Met
(br)	2	160	Arg	Cys
	2	168	Thr	Glu

In the present invention, the term “nitrile hydratase activity” refers to the nitrile-hydrating activity to convert a nitrile group of various compounds to an amide group by hydration, and more preferably refers to the activity to convert acrylonitrile to acrylamide.

In the present invention, the term “improved nitrile hydratase activity” refers to improvement of the initial reaction rate. The “initial reaction rate” in the present invention may be confirmed in the following manner. First, a nitrile hydratase preparation is added to a 50 mM Tris-HCl aqueous solution (pH 8.0) containing 2.5% (v/v) of acrylonitrile as a substrate. In place of the nitrile hydratase preparation, a microorganism cell, a culture or a crude purification product of the nitrile hydratase may be used. After the addition of the nitrile hydratase, the reaction is carried out at 20 degrees centigrade for 15 minutes. 1M phosphoric acid is added to the reaction solution to stop the reaction, and the produced acrylamide is quantitatively analyzed. The amount of acrylamide may be measured through HPLC analysis.

The term “improvement of the initial reaction rate” in the present invention refers to significant improvement of the initial reaction rate as compared to the wild nitrile hydratase and conventionally known nitrile hydratase variant, and specifically refers to improvement of not less than 1.2 times.

The term “improvement of enzyme stability” in the present invention refers to improvement of thermal stability of the nitrile hydratase. The nitrile hydratase with improved thermal stability is expected to increase stability against stress other than heating, i.e., stability against an organic solvent, a high-concentration substrate or a product as well, because structural stability of a protein is considered to be strengthened.

The term “thermal stability of the enzyme” in the present invention may be confirmed in the following manner. First, a nitrile hydratase preparation is heated at 60 degrees centigrade for 2 hours, and then the temperature is returned to 20 degrees centigrade, and a 50 mM Tris-HCl aqueous solution (pH 8.0) containing 2.5% (v/v) of acrylonitrile as a substrate is added thereto. In place of the nitrile hydratase preparation, a microorganism cell, a culture or a crude purification product of the nitrile hydratase may be used. The heated nitrile hydratase and substrate are mixed together, and then reacted at 20 degrees centigrade for 15 minutes to measure the initial reaction rate.

The term “improvement of thermal stability of the enzyme” in the present invention refers to significant improvement of the initial reaction rate after heating as compared to the wild nitrile hydratase and conventionally known nitrile hydratase variant heated in the same manner, and specifically refers to improvement of not less than 1.2 times.

As the wild nitrile hydratase in the present invention, preferably used is Pseudonocardia thermophila-derived nitrile hydratase as disclosed in Patent Document 1. As the plasmid expressing a large number of the wild nitrile hydratase in the transformant and a transformant strain transformed with the plasmid, there may be cited MT-10822 (deposited with the International Patent Organism Depositary at the National Institute of Advanced Industrial Science and Technology, 1-1-1 Higashi, Tsukuba-shi, Ibaraki-ken, Japan, under the deposit number FERM BP-5785, as of Feb. 7, 1996). As the conventionally known nitrile hydratase variant in the present invention, there may be cited the nitrile hydratase variant described in Patent Documents 1 to 4.

The nitrile hydratase variant of the present invention has the following properties in addition to improvement of the nitrile hydratase activity. The enzyme comprises a dimer having the α-subunit and the β-subunit which are in association as the fundamental structural unit, and the dimers are further associated to form tetramers. 111th cysteine residue of the α-subunit undergoes a post-translational modification in a cysteine sulfinic acid (Cys-SOOH), while 113th cysteine residue undergoes a post-translational modification in a cysteine sulfenic acid (Cys-SOH). A polypeptide chain of the α-subunit is bonded to a cobalt atom via the modified amino acid residue to form an active center. The reaction may be preferably carried out in the temperature range of 0 to 60 degrees centigrade, while pH during the reaction is usually selected in the range of 4 to 10 and preferably in the range of 6 to 9.

The nitrile hydratase variant of the present invention may be produced in the following manner.

First, a plasmid containing DNA encoding the nitrile hydratase variant is prepared, and a transformant or a transformant strain is obtained by transforming an arbitrary host cell using the plasmid. Subsequently, the nitrile hydratase variant is produced by cultivating the above-mentioned transformant or transformant strain.

The gene encoding a wild nitrile hydratase comprises a base sequence defined in SEQ ID No: 3 in the Sequence Listing and a base sequence defined in SEQ ID No: 4 in the Sequence Listing. The base sequence defined in SEQ ID No: 3 in the Sequence Listing corresponds to the amino acid sequence consisting of SEQ ID No: 1 in the Sequence Listing, while the base sequence defined in SEQ ID No: 4 in the Sequence Listing corresponds to the amino acid sequence consisting of SEQ ID No: 2 in the Sequence Listing. DNA encoding the nitrile hydratase variant can be obtained by performing base substitution of the base sequence defined in SEQ ID No: 3 and/or SEQ ID No: 4. Specifically, substitutions of the amino acid of (a) to (l) shown in Table I may be realized by base substitution, as shown in Table IV-1.

TABLE IV-1
	Sequence ID		Before
	No.	No.	Substitution	After Substitution
(a)	3	274~276	GAC	GAA, GAG
(b)	3	280~282	ATG	ATT, ATC, ATA
(c)	3	589~591	GGC	TGT, TGC
(d)	4	10~12	GTG	ATG
(e)	4	69~71	GTC	ATT, ATC, ATA
(f)	4	235~237	CAC	AAT, AAC
(g)	4	286~288	CAG	CGT, CGG, CGA, CGG,
				AGA, AGG
(h)	4	319~321	CCC	ATG
(i)	4	676~678	GTC	ATT, ATC, ATA
(j)	4	328~330	GAG	AAT, AAC
	4	691~693	GCC	GTT, GTG, GTA, GTG
(k)	4	616~618	CCG	TTA, TTG, CTT, CTC,
				CTA, CTG
	4	688~690	GCG	GAA, GAG
(l)	3	37~39	ATC	TTA, TTG, CTT, CTC,
				CTA, GTG
	3	79~81	ATG	ATT, ATC, ATA
	4	328~330	GAG	AAT, AAC

Furthermore, substitutions of the amino acid illustrated in Table II may be realized by base substitution, as shown in Table IV-2.

TABLE IV-2
	Sequence		Before
	ID No.	No.	Substitution	After Substitution
(m-1)	3	37~39	ATC	TTA TTG, CTT, CTC,
				CTA, CTG
	3	280~282	ATG	ATT, ATC, ATA
(m-2)	3	37~39	ATC	TTA, TTG, CTT, CTC,
				CTA, CTG
	4	286~288	CAG	CGT, CGC, CGA, CGG,
				AGA AGG
(n-1)	3	79~81	ATG	ATT, ATC, ATA
	4	280~282	ATG	ATT, ATC, ATA
(n-2)	3	79~81	ATG	ATT, ATC, ATA
	4	319~321	CCC	ATG
(o)	4	10~12	GTG	ATG
	4	235~237	CAC	AAT, AAC
(p)	4	235~237	CAC	AAT, AAC
	4	688~690	GCG	GAA, GAG
(q)	3	274~276	GAC	GAA, GAG
	4	676~678	GTC	ATT, ATC, ATA
(r)	3	37~39	ATC	TTA, TTG, CTT, CTC,
				CTA CTG
	4	616~618	CCG	TTA, TTG, CTT, CTC,
				CTA, CTG
	4	676~678	GTC	ATT, ATC, ATA
(s)	3	274~276	GAC	GAA, GAG
	4	10~12	GTG	ATG
	4	616~618	CCG	TTA, TTG, CTT, CTC,
				CTA CTG
(t)	3	589~591	GGC	TGT, TGC
	4	319~321	CCC	ATG
	4	688~690	GCG	GAA GAG
(u)	4	235~237	CAC	AAT, AAC
	4	688~690	GCG	GAA, GAG
	4	691~693	GCC	GTT, GTC, GTA, GTG
(v)	3	274~276	GAC	GAA, GAG
	4	69~71	GTC	ATT, ATC, ATA
	4	676~678	GTC	ATT, ATC, ATA
(w)	3	589~591	GGC	TGT, TGC
	4	69~71	GTC	ATT, ATC, ATA
	4	319~321	CCC	ATG
	4	688~690	GCG	GAA, GAG
(x)	4	69~71	GTC	ATT, ATC, ATA
	4	235~237	CAC	AAT, AAC
	4	688~690	GCG	GAA, GAG
	4	691~693	GCC	GTT, GTC, GTA, GTG

Furthermore, substitutions of the amino acid illustrated in Table III may be realized by base substitution, as shown in Table V.

TABLE V
	Sequence		Before
	ID No.	No.	Substitution	After Substitution
(aa)	3	106~108	ACG	ATG
	3	376~378	TTC	TAT, TAC
(ab)	3	442~444	GGC	GAU, GAC
	3	610~612	GTC	CGT, CGC, CGA, CGG,
				AGA, AGG
(ac)	4	151~153	TTC	GTT, GTC, GTA, GTG
	4	322~324	GAG	GAT, GAC
(ad)	4	352~354	TTC	GTT, GTC, GTA, GTG
	4	598~600	GCC	GAA, GAG
(ae)	4	478~480	CGG	TGG
	4	556~558	CTG	CGT, CGC, CGA, CGG,
				AGA, AGG
(af)	3	16~18	CTG	ACT, ACC, ACA, ACG
	3	106~108	ACG	ATG
	3	376~378	TTC	TAT, TAC
(ag)	3	55~57	GCG	GTT, GTC, GTA, GTG
	3	211~213	CGT	CAT, CAC
	3	376~378	TTC	TAT, TAC
(ah)	3	106~108	ACG	ATG
	3	442~444	GGC	GAT, GAC
	3	610~612	GTC	CGT, CGC, CGA, CGG,
				AGA, AGG
(ai)	4	28~30	ACC	GAT, GAC
	4	352~354	TTC	GTT, GTC, GTA,
				GTG
	4	598~600	GCC	GAA, GAG
(aj)	4	109~111	TTC	TTA, TTG, CTT, CTC,
				CTA, CTG
	4	322~324	GAG	GAT, GAC
	4	598~600	GCC	GAA, GAG
(ak)	4	109~111	TTC	GTT, GTC, GTA, GTG
	4	322~324	GAG	GAT, GAC
	4	598~600	GCC	GAA, GAG

	TABLE V-1
	(al)	4	121~123	TTC	ATT, ATC, ATA
		4	151~153	TTC	GTT, GTC, GTA, GTG
		4	322~324	GAG	GAT, GAC
	(am)	4	136~138	ATG	AAA, AAG
		4	322~324	GAG	CGT, CGC, CGA, CGG,
					AGA, AGG
		4	634~636	TCC	TAT, TAC
	(an)	4	142~144	CTG	GTT, GTC, GTA, GTG
		4	322~324	GAG	CGT, CGC, CGA, CGG,
					AGA, AGG
		4	634~636	TCC	TAT, TAC
	(ao)	4	379~381	CTG	TCT, TCC, TCA, TCG,
					AGT, AGC
		4	478~480	CGG	TGG
		4	556~558	CTG	CGT, CGC, CGA, CGG,
					AGA, AGG
	(ap)	3	16~18	CTG	ACT, ACC, ACA, ACG
		3	55~57	GCG	GTT, GTC, GTA, GTG
		3	376~378	TTC	TAT, TAC
		4	136~138	ATG	AAA, AAG
		4	322~324	GAG	CGT, CGC, CGA, CGG,
					AGA, AGG
		4	634~636	TCC	TAT, TAC
	(aq)	3	16~18	CTG	ACT, ACC, ACA, ACG
		3	55~57	GCG	GTT, GTC, GTA, GTG
		3	376~378	TTC	TAT, TAC
		4	142~144	CTG	GTT, GTC, GTA, GTG
		4	322~324	GAG	CGT, CGC, CGA, CGG,
					AGA, AGG
		4	634~636	TCC	TAT, TAC
	(ar)	3	16~18	CTG	GOT, GCC, GCA, GCG
		3	55~57	GCG	GTT, GTC, GTA, GTG
		3	376~378	TTC	TAT, TAC
		4	379~381	CTG	TCT, TCC, TCA, TCG,
					AGU, AGC
		4	478~480	CGG	TGG
		4	556~558	CTG	CGT, CGC, CGA, CGG,
					AGA, AGG

	TABLE V-2
	(as)	3	16~18	CTG	ACT, ACC, ACA, ACG
		3	106~108	ACG	ATG
		3	376~378	TTC	TAT, TAC
		4	28~30	ACC	GAT, GAC
		4	352~354	TTC	GTT, GTC, GTA, GTG
		4	598~600	GCC	GAA, GAG
	(at)	3	55~57	GCG	GTT, GTC, GTA, GTG
		3	211~213	CGT	CAT, CAC
		3	376~378	TTC	TAT, TAC
		4	109~111	TTC	TTA, TTG, CTT, CTC,
					CTA, CTG
		4	322~324	GAG	GAT, GAC
		4	598~600	GCC	GAA, GAG
	(au)	3	55~57	GCG	GTT, GTC, GTA, GTG
		3	211~213	CGT	CAT, CAC
		3	376~378	TTC	TAT, TAC
		4	109~111	TTC	GTT, GTC, GTA, GTG
		4	322~324	GAG	GAT, GAC
		4	598~600	GCC	GAA, GAG
	(av)	3	106~108	ACG	ATG
		3	442~444	GGC	GAT, GAC
		3	610~612	GTC	CGT, CGC, CGA, CGG,
					AGA, AGG
		4	121~123	TTC	ATT, ATC, ATA
		4	151~153	TTC	GTT, GTC, GTA, GTG
		4	322~324	GAG	GAT, GAC
	(aw)	3	442~444	GGC	GAT, GAC
		3	610~612	GTC	CGT, CGC, CGA, CGG,
					AGA, AGG
		4	322~324	GAG	GAT, GAC
		4	598~600	GCC	GAA, GAG
	(ax)	3	106~108	ACG	GGT, GGC, GGA, GGG
		3	562~564	ACC	GGT, GGC, GGA, GGG

	TABLE V-3
	(ay)	3	106~108	ACG	GCT, GCC, GCA, GCG
		3	142~144	AAC	CAA, CAG
	(az)	3	142~144	AAC	GAA, GAG
		4	436~438	CGG	GGT, GGC, GGA, GGG
	(ba)	3	106~108	ACG	TGG
		4	526~528	TAC	TGT, TGC
	(bb)	4	526~528	TAC	ATG
		4	649~651	GAC	GGT, GGC, GGA, GGG
	(bc)	3	106~108	ACG	TCT, TCC, TCA, TCG,
					AGT, AGC
		4	97~99	GCG	GTT, GTC, GTA, GTG
	(bd)	4	526~528	TAC	GCT, GCC, GCA, GCG
		4	649~651	GAC	GTT, GTC, GTA, GTG
	(be)	4	118~120	ACG	GTT, GTC, GTA, GTG
		4	652~654	TGC	ATG
	(bf)	4	97~99	GCG	ATG
		4	526~528	TAC	ACT, ACC, ACA, ACG
	(bg)	4	118~120	ACG	TTA, TTG, CTT, CTC,
					CTA, CTG
		4	649~651	GAC	TTA, TTG, CTT, CTC,
					CTA, CTG
	(bh)	4	118~120	ACG	ATT, ATC, ATA
		4	181~183	GCC	GTT, GTC, GTA, GTG
	(bi)	4	181~183	GCC	ACT, ACC, ACA, ACG
		4	652~654	TGC	TCT, TCC, TCA, TCG,
					AGT, AGC
	(bj)	4	334~336	AAG	GTT, GTC, GTA, GTG
		4	649~651	GAC	ATG
	(bk)	4	181~183	GCC	TGG
		4	649~651	GAC	CAT, CAC
	(bl)	4	181~183	GCC	TTA, TTG, CTT, CTC,
					CTA, CTG
		4	334~336	AAG	ATT, ATC, ATA

	TABLE V-4
	(bm)	4	436~438	CGG	GGT, GGC, GGA, GGG
		4	649~651	GAC	TCT, TCC, TCA, TCG,
					AGT, AGC
	(bn)	4	511~513	AAG	GCT, GCC, GCA, GCG
		4	649~651	GAC	ACT, ACC, ACA, ACG
	(bo)	4	448~450	GCG	TCT, TCC, TCA, TCG,
					AGT, AGC
		4	649~651	GAC	TGT, TGC
	(bp)	4	181~183	GCC	GGT, GGC, GGA, GGG
		4	448~450	GCG	AAT, AAC
	(bq)	4	181~183	GCC	TCT, TCC, TCA, TCG,
					AGT, AGC
		4	478~480	CGG	ATG
	(br)	4	478~480	CGG	TGT, TGC
		4	502~504	ACG	GAA, GAG

The plasmid can have, in addition to a gene encoding the α-subunit of the nitrile hydratase variant, a gene encoding the β-subunit or a nitrile hydratase variant gene or nitryl hydratase variant gene, a constitution which enables the production of a nitrile hydratase by a transformant or a transformant strain obtained by transforming an arbitrary host cell, such as the regulatory region necessary for the expression of each gene, the region necessary for autonomous replication or the like. The arbitrary host cell as used herein may be exemplified by Escherichia coli.

The regulatory region necessary for expression may include a promoter sequence (including the transcription-regulating operator sequence), a ribosome binding sequence (SD sequence), a transcription-terminating sequence and the like. Specific examples of the promoter sequence may include a trp promoter of tryptophan operon and a lac promoter of lactose operon that are derived from Escherichia coli, and a PL promoter and a PR promoter that are derived from lambda phage. Further, artificially designed or improved sequences such as a tac promoter or a trc promoter may also be used.

The ribosome binding sequence is preferably a sequence having TAAGGAGGT contained in SEQ ID No: 7. The sequence order of these regulatory regions on a plasmid is preferably such that the promoter sequence and the ribosome binding sequence are located upstream to the 5′-terminal than the gene encoding the nitrile hydratase variant, and the transcription-terminating sequence is preferably located downstream to the 3′-terminal than the gene encoding the nitrile hydratase variant. Also, the α-subunit gene and the β-subunit gene of the nitrile hydratase variant may be expressed as individual independent cistrons by means of such regulatory regions, or may be expressed as a polycistron by means of a common regulatory region.

Examples of the plasmid vector satisfying the above requirements may include pBR322, pUC18, pBluescript, pKK223-3 and pSC101, which have a region capable of autonomous replication in Escherichia coli.

For a method of constructing the plasmid of the present invention by inserting the gene encoding the nitrile hydratase variant of the present invention into such a plasmid vector, together with those regions necessary for expression of the activity of the nitrile hydratase variant, a method of transforming the plasmid to a desired host cell and a method of producing nitrile hydratase in the transformant, there may be used those general methods and host cells known in the art of molecular biology, biological engineering and genetic engineering as described in, for example, “Molecular Cloning, 3rd Edition” (J. Sambrook et al., Cold Spring Harbor Laboratory Press, 2001) or the like.

The transformant obtained by transforming the above plasmid to a desired host cell is cultivated in a culture medium, whereby the nitrile hydratase variant can be produced based on the nitrile hydratase gene carried by the plasmid. When the host cell is Escherichia coli, LB medium, M9 medium or the like is generally used as the culture medium for cultivating the transformant. More preferably, these medium components may comprise Fe ions and Co ions in an amount of 0.1 μg/mL or more, or the transformant may be inoculated and then cultivated at a suitable cultivating temperature (in general, from 20 to 50 degrees centigrade).

When the nitrile hydratase variant having the desired enzyme activity to express the gene encoding the nitrile hydratase variant of the present invention is produced, a gene encoding a protein involved in the activation of nitrile hydratase may be required in some cases.

A protein involved in the activation of nitrile hydratase is a protein having the property such that the presence or absence of the expression of the protein directly controls the activation of nitrile hydratase, and it can be exemplified by the protein involved in the activation of Pseudonocardia thermophila-derived nitrile hydratase (nitrile hydratase-activating protein) as described in Japanese Patent Laid-open No. H11 (1999)-253168. The sequence of the nitrile hydratase-activating protein is presented in the Sequence Listing: 5 and 6.

The amide compound can be produced in the following manner using the nitrile hydratase variant of the present invention. First, the transformant or transformant strain to produce the nitrile hydratase variant of the present invention is caltivated, and a given cell or a given product obtained by processing the cells is brought into contact with a nitrile compound in a solvent. In this manner, a corresponding amide compound is produced.

The term “product obtained by processing the cells” mentioned herein refers to an extract or a disruption product of the transformant, a post-separation product such as a crude enzyme preparation obtained by isolating the nitrile hydratase activated fraction from such extract or disruption product, an enzyme purification product obtained by further purification or the like, and an immobilization product in which the transformant, or an extract, a disruption product or a post-separation product of the transformant is immobilized by using suitable means. The contact temperature is not particularly limited, but it is preferably in the range of not deactivating the nitrile hydratase variant, and more preferably from 0 to 60 degrees centigrade. As the nitrile compound, there is no particular limitation as long as it is a compound which can act as the substrate for the nitrile hydratase variant of the present invention, and it can be preferably exemplified by nitrile compounds having 2 to 4 carbon atoms, such as acetonitrile, propionitrile, acrylonitrile, methacrylonitrile, n-butyronitrile, isobutyronitrile, crotononitrile, α-hydroxyisobutyronitrile and the like. The concentration of the nitrile compound in the aqueous medium is not particularly limited. The reaction temperature is not particularly limited, but it is preferably in the range of not deactivating the nitrile hydratase, and more preferably from 0 to 60 degrees centigrade. Furthermore, in order to produce an amide compound with a smaller amount of the enzyme, it is preferable to use a nitrile hydratase variant having a certain level of stability under conditions of producing an amide compound.

Subsequently, the operational effect of the present invention will be described in detail. The present inventors have repeatedly conducted an extensive study and as a result, have found a nitrile hydratase variant in which both physical properties relating to the reaction itself and the enzyme stability are improved as compared to the conventional nitrile hydratase, comprising substitution of at least one amino acid with another amino acid to improve two or more properties of nitrile hydratase by substitution of one or more and three or less amino acids. In particular, they have found that with respect to the nitrile hydratase comprising the α-subunit defined in SEQ ID No: 1 in the Sequence Listing and the β-subunit defined in SEQ ID No: 2 in the Sequence Listing, at least one amino acid is substituted with another amino acid, selected from substitution sites of the amino acid consisting of the above (a) to (l), whereby enzyme stability as well as the initial reaction rate of the nitrile hydratase can be improved at the same time. In this way, both of efficiency of the enzymatic reaction and handling of the enzyme can be achieved. Also, by use of the nitrile hydratase in which both of the initial reaction rate and enzyme stability are enhanced, the activity value in a unit weight of the enzyme preparation can be increased, and at the same time the risk of enzyme deactivation due to temperature variation or the like for the industrial use can be reduced. Accordingly, the amide compound can be stably produced with a smaller amount of the enzyme so that the production costs for producing the amide compound can be reduced.

As described above, embodiments of the present invention has been described, but the embodiments described in the present invention are illustrative only, and various other constructions may also be adopted.

EXAMPLES

The present invention is now illustrated in detail below with reference to the following Examples. However, the present invention is not restricted to these Examples.

Example 1

Construction of Plasmid (1) Expressing Nitrile Hydratase with Modified Ribosome Binding Sequence

A gene fragment of about 0.7 kbp was obtained by the PCR reaction using a plasmid pPT-DB1 described in Example 3 of Patent Document 1 as the template and the primers defined in SEQ ID Nos: 7 and 8 in the Sequence Listing. The above-mentioned PCR fragment was cleaved by means of restriction endonucleases EcoRI and NotI, and then this mixture treated with restriction endonucleases was subjected to phenol/chloroform extraction and ethanol precipitation to purify the DNA fragment. In the same manner, pPT-DB1 was cleaved by means of EcoRI and NotI, and then subjected to agarose gel electrophoresis, through which only the DNA fragment of about 3.9 kbp was cut out of the agarose gel. The thus obtained DNA fragments of about 0.7 kbp and of about 3.9 kbp were subjected to DNA ligation using a DNA ligation kit (manufactured by Takara Shuzo Co., Ltd.) to prepare a plasmid (1) expressing the above-mentioned nitrile hydratase with the modified ribosome binding sequence.

A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (1). Moreover, the plasmid was prepared from the above microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (1) had the modified ribosome binding sequence in pPT-DB1 as shown in Table 1.

In the production of an amide compound using the thus obtained transformant (1) and a transformant MT-10822 containing pPT-DB1 (deposited with the International Patent Organism Depositary at the National Institute of Advanced Industrial Science and Technology, 1-1-1 Higashi, Tsukuba-shi, Ibaraki-ken, Japan, under the deposit number FERM BP-5785 from Feb. 7, 1996) to be its base, the initial reaction rates were compared in the following method.

Comparison of Initial Reaction Rate

5 mL of a liquid LB medium containing 40 μg/mL of ferric sulfate heptahydrate and 10 μg/mL of cobalt chloride dihydrate was prepared in a test tube, and sterilized by autoclaving at 121 degrees centigrade for 20 minutes. Ampicillin was added to this medium to have a final concentration of 100 μg/mL. Then, on the medium, one platinum loop of respective transformants was inoculated and cultivated therein at 37 degrees centigrade for about 20 hours with stirring at 200 rpm. 40 μL of the resulting culture was taken and suspended in 740 μL of a 54 mM Tris-HCl aqueous solution (pH 8.0). To this, 20 μL of acrylonitrile was added, and this mixture was gently stirred at 20 degrees centigrade for 15 minutes to react, whereby acrylamide was produced. After completion of the reaction, the content of acrylamide in the reaction solution was analyzed through HPLC.

Comparison of Thermal Stability of Enzyme

Respective transformants were separated from the resulting culture of the above-mentioned transformants by centrifugation (5,000 G×15 minutes).

0.1 g of the thus isolated transformants were respectively suspended in 20 ml of a 50 mM Tris-HCl aqueous solution (pH 8.0), and heated at 60 degrees centigrade for 2 hours. The temperature was returned to 20 degrees centigrade after heating, and 0.5 ml of acrylonitrile was added thereto as the substrate. The reaction was carried out at 20 degrees centigrade for 15 minutes to measure the initial reaction rate.

Analytical Conditions

Analytical Equipment: HPLC manufactured by JASCO Corporation

Column: YMC Pack ODS-A (150×6.00 mm)

Analytical Temperature: 40 degrees centigrade

Mobile Phase: 3% acetonitrile, 10 mM phosphoric acid

Respective transformants were subjected to the reaction and analysis three times or more to correct variations in the data by means of a dispensing operation or the like.

As a result of comparison of the initial reaction rate and thermal stability of the transformant (1) and MT-10822, that is, the amount of produced acrylamide under the above reaction conditions, improvement of the initial reaction rate by 1.15 times was observed and thermal stability was maintained with the new addition of the modified ribosome binding sequence shown in Table 1.

TABLE 14
Table 1
				Effect on	Effect on
				Improvement	Improvement
				of Reaction	of Thermal
				Rate by	Stability by
				Ribosome	Ribosome
		Change in Base Sequence	Binding	Binding
Transformant	Mutated	Before	After	Sequence	Sequence
No.	Site	Substitution	Substitution	Substitution	Substitution
1	Ribosome	TGAGAGGAG	TAAGGAGGT	1.15 times	1.00 times
	Binding
	Sequence

Reference Example 1

Construction of a Transformant (2) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (2) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (av) amino acid substitution sites as shown in Table 2, the plasmid described in Example 79 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified in the method described in Example 1 to prepare a plasmid (2) encoding the above-mentioned nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (2).

Reference Example 2

Construction of a Transformant (3) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (3) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bc) amino acid substitution sites as shown in Table 2, introduction of site-specific mutation was performed using a “LA PCR in vitro mutagenesis Kit” manufactured by Takara Shuzo Co., Ltd. (hereinafter referred to as the mutagenesis kit). The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template to carry out the PCR reaction.

For the PCR reaction No. 1, a reaction system of 50 μL in total containing 50 pmols of the primer having the sequence defined in SEQ ID No: 9 in the Sequence Listing and 50 pmols of an M13 primer M4 (having the sequence defined in SEQ ID No: 10 in the Sequence Listing) (for the composition of the system, the instructions described in the mutagenesis kit were followed) was used, and the reaction consisted of 25 PCR cycles, in which one PCR cycle comprised thermal denaturation (98 degrees centigrade) for 15 seconds, annealing (55 degrees centigrade) for 30 seconds and chain extension (72 degrees centigrade) for 120 seconds.

For the PCR reaction No. 2, a reaction system of 50 μL in total containing 50 pmols of an MUT4 primer (having the sequence defined in SEQ ID No: 11 in the Sequence Listing) and an M13 primer RV (having the sequence defined in SEQ ID No: 12 in the Sequence Listing) (for the composition of the system, the instructions described in the mutagenesis kit were followed) was used, and the reaction was carried out following the same procedure as the PCR reaction No. 1.

After completion of the PCR reaction Nos. 1 and 2, 5 μL of the reaction mixture was subjected to agarose gel electrophoresis (where the agarose concentration was 1.0 weight %), and an analysis of the DNA amplification product was carried out. As a result, the presence of the amplified DNA product was confirmed. From each of these PCR reaction mixtures, the excess primers and dNTP were removed using Microcon 100 (manufactured by Takara Shuzo Co., Ltd.), and then TE was added to each of the mixtures to prepare 50 μL each of TE solutions. An annealing solution of 47.5 μL in total containing 0.5 μL of both of the above TE solutions (for the composition of the system, the instructions described in the mutagenesis kit were followed) was prepared, and this solution was subjected to annealing by performing thermal denaturation of the solution at 98 degrees centigrade for 10 minutes, subsequently cooling the solution to 37 degrees centigrade at a constant cooling rate over a period of 60 minutes, and then maintaining it at 37 degrees centigrade for 15 minutes. To the thus annealed solution, 0.5 μL of TaKaRa LA Taq (manufactured by Takara Bio Inc.) was added, and the solution was heated at 72 degrees centigrade for 3 minutes, thus completing the formation of heterologous double-stranded DNA.

To this was added 50 pmols of an M13 primer M4 (having the sequence defined in SEQ ID No: 10 in the Sequence Listing) and 50 pmols of an M13 primer RV (having the sequence defined in SEQ ID No: 12 in the Sequence Listing) to give a reaction system of 50 μL in total, and the reaction consisted of 25 PCR cycles, in which one PCR cycle comprised thermal denaturation (98 degrees centigrade) for 15 seconds, annealing (55 degrees centigrade) for 30 seconds and chain extension (72 degrees centigrade) for 120 seconds to carry out the PCR reaction No. 3. After completion of the PCR reaction No. 3, 5 μL of the reaction mixture was subjected to agarose gel electrophoresis (using Type VII low-melting-point agarose, a product by Sigma Corporation; agarose concentration of 0.8 weight %), and an analysis of the DNA amplification product was carried out. As a result, the presence of the amplified DNA product of about 2 kb was confirmed.

Subsequently, an agarose fragment comprising only the DNA fragment of about 2 kb was cut out of the agarose gel. The thus cut agarose fragment (about 0.1 g) was finely pulverized, suspended in 1 ml of a TE solution, and then kept at 55 degrees centigrade for 1 hour, whereby the agarose fragment was completely melted. The resulting agarose melt was then subjected to phenol/chloroform extraction and ethanol precipitation to purify the DNA fragment. The thus purified DNA fragment was finally dissolved in 10 μL of TE. The amplified DNA fragment of about 2 kb thus purified was cleaved by means of restriction endonucleases EcoRI and HindIII, and this mixture treated with restriction endonucleases was then subjected to phenol/chloroform extraction and ethanol precipitation to purify the DNA fragment. The thus purified DNA fragment was finally dissolved in 10 μL of TE.

Likewise, the plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was cleaved by means of EcoRI and HindIII, and then subjected to agarose gel electrophoresis (using Type VII low-melting-point agarose, a product by Sigma Corporation; agarose concentration of 0.7%). An agarose fragment comprising only the DNA fragment of about 2.7 kb was cut out of the agarose gel. The thus cut agarose fragment (about 0.1 g) was finely pulverized, suspended in 1 ml of the TE solution, and then kept at 55 degrees centigrade for 1 hour, whereby the agarose fragment was completely melted. The resulting agarose melt was then subjected to phenol/chloroform extraction and ethanol precipitation to purify the DNA fragment. The thus purified DNA fragment was finally dissolved in 10 μL of TE.

The thus obtained DNA fragments of about 2 kbp and of about 2.7 kbp were subjected to DNA ligation, using a DNA ligation kit (manufactured by Takara Shuzo Co., Ltd.). Then, a competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed. The above operation was carried out using the plasmid extracted from the transformant as the template, and using the primer having the sequence defined in SEQ ID No: 13 instead of the primer defined in SEQ ID No: 9, whereby a plasmid (3) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (3).

Reference Example 3

Construction of a Transformant (4) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (4) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bh) amino acid substitution sites as shown in Table 2, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 14 and 15 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (4) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (4).

TABLE 2
		Change in Amino Acid	Change in
Trans-		Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
2	α-36th	Thr	Met	ACG	ATG
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
3	α-36th	Thr	Ser	ACG	TCG
	β-33rd	Ala	Val	GCG	GTG
4	β-40th	Thr	Ile	ACG	ATT
	β-61st	Ala	Val	GCC	GTC

Example 2

Construction of a Transformant (5) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (5) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (a) and (av) amino acid substitution sites as shown in Table 3, the plasmid (2) recovered from the transformant (2) described in the above Reference Example 1 was used as the template, and the primer having the sequence defined in SEQ ID No: 16 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (5) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (5). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (5) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu was newly added to the plasmid (2) of Reference Example 1.

In the production of an amide compound using the thus obtained transformant (5) and the transformant (2) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu was newly added to the transformant (5), so that the initial reaction rate was improved by 1.65 times and thermal stability was improved by 1.25 times, as compared to those of the transformant (2).

Example 3

Construction of a Transformant (6) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (6) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (a) and (bc) amino acid substitution sites as shown in Table 3, the plasmid (3) recovered from the transformant (3) described in the above Reference Example 2 was used as the template, and the primer having the sequence defined in SEQ ID No: 16 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (6) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (6). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (6) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu was newly added to the plasmid (3) of Reference Example 2. In the production of an amide compound using the thus obtained transformant (6) and the transformant (3) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu was newly added to the transformant (6), so that the initial reaction rate was improved by 1.63 times and thermal stability was improved by 1.23 times, as compared to those of the transformant (3).

Example 4

Construction of a Transformant (7) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (7) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (a) and (bh) amino acid substitution sites as shown in Table 3, the plasmid (4) recovered from the transformant (4) described in the above Reference Example 3 was used as the template, and the primer having the sequence defined in SEQ ID No: 16 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (7) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (7). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (7) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu was newly added to the plasmid (4) of Reference Example 3. In the production of an amide compound using the thus obtained transformant (7) and the transformant (4) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu was newly added to the transformant (7), so that the initial reaction rate was improved by 1.58 times and thermal stability was improved by 1.30 times, as compared to those of the transformant (4).

	TABLE 3
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	α-92nd	α-92nd
No.	Site	tion	tion	tion	tion	Substitution	Substitution
5	α-36th	Thr	Met	ACG	ATG	1.65 times	1.25 times
	α-92nd	Asp	Glu	GAC	GAG
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
6	α-36th	Thr	Ser	ACG	TCG	1.63 times	1.23 times
	α-92nd	Asp	Glu	GAC	GAG
	β-33rd	Ala	Val	GCG	GTG
7	α-92nd	Asp	Glu	GAC	GAG	1.58 times	1.30 times
	β-40th	Thr	Ile	ACG	ATT
	β-61st	Ala	Val	GCC	GTC

Reference Example 4

Construction of a Transformant (8) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (8) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ak) amino acid substitution sites as shown in Table 4, the plasma described in Example 68 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (8) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (8).

Reference Example 5

Construction of a Transformant (9) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (9) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ap) amino acid substitution sites as shown in Table 4, the plasma described in Example 73 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (9) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (9).

Reference Example 6

Construction of a Transformant (10) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (10) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bp) amino acid substitution sites as shown in Table 4, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 17 and 18 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (10) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (10).

TABLE 4
		Change in Amino Acid	Change in
Trans-		Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
8	β-37th	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
9	α-6th	Leu	Thr	CTG	ACG
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-46th	Met	Lys	ATG	AAG
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
10	β-61st	Ala	Gly	GCC	GGC
	β-150th	Ala	Asn	GCG	AAT

Example 5

Construction of a Transformant (11) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (11) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (b) and (ak) amino acid substitution sites as shown in Table 5, the plasmid (8) recovered from the transformant (8) described in the above Reference Example 4 was used as the template, and the primer having the sequence defined in SEQ ID No: 19 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (11) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (11). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (11) had sequences according to the purpose in which mutation of 94th Met in the α-subunit with Ile was newly added to the plasmid (8) of Reference Example 4. In the production of an amide compound using the thus obtained transformant (11) and the transformant (8) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 94th Met in the α-subunit with Ile was newly added to the transformant (11), so that the initial reaction rate was improved by 1.45 times and thermal stability was improved by 1.38 times, as compared to those of the transformant (8).

Example 6

Construction of a Transformant (12) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (12) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (b) and (ap) amino acid substitution sites as shown in Table 5, the plasmid (9) recovered from the transformant (9) described in the above Reference Example 5 was used as the template, and the primer having the sequence defined in SEQ ID No: 19 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (12) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (12). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (12) had sequences according to the purpose in which mutation of 94th Met in the α-subunit with Ile was newly added to the plasmid (9) of Reference Example 5. In the production of an amide compound using the thus obtained transformant (12) and the transformant (9) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 94th Met in the α-subunit with Ile was newly added to the transformant (12), so that the initial reaction rate was improved by 1.40 times and thermal stability was improved by 1.25 times, as compared to those of the transformant (9).

Example 7

Construction of a Transformant (13) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (13) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (b) and (bp) amino acid substitution sites as shown in Table 5, the plasmid (10) recovered from the transformant (10) described in the above Reference Example 6 was used as the template, and the primer having the sequence defined in SEQ ID No: 19 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (13) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (13). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (13) had sequences according to the purpose in which mutation of 94th Met in the α-subunit with Ile was newly added to the plasmid (10) of Reference Example 6. In the production of an amide compound using the thus obtained transformant (13) and the transformant (10) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 94th Met in the α-subunit with Ile was newly added to the transformant (13), so that the initial reaction rate was improved by 1.32 times and thermal stability was improved by 1.35 times, as compared to those of the transformant (10).

	TABLE 5
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	α-94th	α-94th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
11	α-94th	Met	Ile	ATG	ATC	1.45 times	1.38 times
	β-37th	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
12	α-6th	Leu	Thr	CTG	ACG	1.40 times	1.25 times
	α-19th	Ala	Val	GCG	GTG
	α-94th	Met	Ile	ATG	ATC
	α-126th	Phe	Tyr	TTC	TAC
	β-46th	Met	Lys	ATG	AAG
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
13	α-94th	Met	Ile	ATG	ATC	1.32 times	1.35 times
	β-61st	Ala	Gly	GCC	GGC
	β-150th	Ala	Asn	GCG	AAT

Reference Example 7

Construction of a Transformant (14) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (14) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (an) amino acid substitution sites as shown in Table 6, the plasma described in Example 71 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (14) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (14).

Reference Example 8

Construction of a Transformant (15) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (15) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (be) amino acid substitution sites as shown in Table 6, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 20 and 21 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (15) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (15).

Reference Example 9

Construction of a Transformant (16) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (16) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (br) amino acid substitution sites as shown in Table 6, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 22 and 23 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (16) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (16).

TABLE 6
		Change in Amino Acid	Change in
Trans-		Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
14	β-48th	Leu	Val	CTG	GTG
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
15	β-40th	Thr	Val	ACG	GTG
	β-218th	Cys	Met	TGC	ATG
16	β-160th	Arg	Cys	CGG	TGT
	β-168th	Thr	Glu	ACG	GAG

Example 8

Construction of a Transformant (17) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (17) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (c) and (an) amino acid substitution sites as shown in Table 7, the plasmid (14) recovered from the transformant (14) described in the above Reference Example 7 was used as the template, and the primer having the sequence defined in SEQ ID No: 24 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (17) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (17). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (17) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys was newly added to the plasmid (14) of Reference Example 7. In the production of an amide compound using the thus obtained transformant (17) and the transformant (14) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys was newly added to the transformant (17), so that the initial reaction rate was improved by 1.80 times and thermal stability was improved by 1.25 times, as compared to those of the transformant (14).

Example 9

Construction of a Transformant (18) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (18) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (c) and (be) amino acid substitution sites as shown in Table 7, the plasmid (15) recovered from the transformant (15) described in the above Reference Example 8 was used as the template, and the primer having the sequence defined in SEQ ID No: 24 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (18) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (18). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (18) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys was newly added to the plasmid (15) of Reference Example 8. In the production of an amide compound using the thus obtained transformant (18) and the transformant (15) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys was newly added to the transformant (18), so that the initial reaction rate was improved by 1.86 times and thermal stability was improved by 1.40 times, as compared to those of the transformant (15).

Example 10

Construction of a Transformant (19) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (19) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (c) and (br) amino acid substitution sites as shown in Table 7, the plasmid (16) recovered from the transformant (16) described in the above Reference Example 9 was used as the template, and the primer having the sequence defined in SEQ ID No: 24 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (19) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (19). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (19) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys was newly added to the plasmid (16) of Reference Example 9. In the production of an amide compound using the thus obtained transformant (19) and the transformant (16) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys was newly added to the transformant (19), so that the initial reaction rate was improved by 1.68 times and thermal stability was improved by 1.20 times, as compared to those of the transformant (16).

	TABLE 7
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	α-197th	α-197th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
17	α-197th	Gly	Cys	GGC	TGC	1.80 times	1.25 times
	β-48th	Leu	Val	CTG	GTG
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
18	α-197th	Gly	Cys	GGC	TGC	1.86 times	1.40 times
	β-40th	Thr	Val	ACG	GTG
	β-218th	Cys	Met	TGC	ATG
19	α-197th	Gly	Cys	GGC	TGC	1.68 times	1.20 times
	β-160th	Arg	Cys	CGG	TGT
	β-168th	Thr	Glu	ACG	GAG

Reference Example 10

Construction of a Transformant (20) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (20) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ar) amino acid substitution sites as shown in Table 8, the plasma described in Example 75 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (20) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (20).

Reference Example 11

Construction of a Transformant (21) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (21) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ax) amino acid substitution sites as shown in Table 8, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 25 and 26 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (21) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (21).

Reference Example 12

Construction of a Transformant (22) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (22) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bd) amino acid substitution sites as shown in Table 8, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 27 and 28 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (22) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (22).

TABLE 8
		Change in Amino Acid	Change in
Trans-		Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
20	α-6th	Leu	Ala	CTG	GCG
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-127th	Leu	Ser	CTG	TCG
	β-160th	Arg	Trp	CGG	TGG
	β-186th	Leu	Arg	CTG	CGG
21	α-36th	Thr	Gly	ACG	GGG
	α-188th	Thr	Gly	ACC	GGC
22	β-176th	Tyr	Ala	TAC	GCC
	β-217th	Asp	Val	GAC	GTC

Example 11

Construction of a Transformant (23) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (23) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (d) and (ar) amino acid substitution sites as shown in Table 9, the plasmid (20) recovered from the transformant (20) described in the above Reference Example 10 was used as the template, and the primer having the sequence defined in SEQ ID No: 29 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (23) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (23). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (23) had sequences according to the purpose in which mutation of 4th Val in the β-subunit with Met was newly added to the plasmid (20) of Reference Example 10. In the production of an amide compound using the thus obtained transformant (23) and the transformant (20) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 4th Val in the β-subunit with Met was newly added to the transformant (23), so that the initial reaction rate was improved by 1.25 times and thermal stability was improved by 1.35 times, as compared to those of the transformant (20).

Example 12

Construction of a Transformant (24) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (24) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (d) and (ax) amino acid substitution sites as shown in Table 9, the plasmid (21) recovered from the transformant (21) described in the above Reference Example 11 was used as the template, and the primer having the sequence defined in SEQ ID No: 29 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (24) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (24). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (24) had sequences according to the purpose in which mutation of 4th Val in the β-subunit with Met was newly added to the plasmid (21) of Reference Example 11. In the production of an amide compound using the thus obtained transformant (24) and the transformant (21) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 4th Val in the β-subunit with Met was newly added to the transformant (24), so that the initial reaction rate was improved by 1.32 times and thermal stability was improved by 1.39 times, as compared to those of the transformant (21).

Example 13

Construction of a Transformant (25) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (25) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (d) and (bd) amino acid substitution sites as shown in Table 9, the plasmid (22) recovered from the transformant (22) described in the above Reference Example 12 was used as the template, and the primer having the sequence defined in SEQ ID No: 29 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (25) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (19).

Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (25) had sequences according to the purpose in which mutation of 4th Val in the β-subunit with Met was newly added to the plasmid (22) of Reference Example 12. In the production of an amide compound using the thus obtained transformant (25) and the transformant (22) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result of comparison of the initial reaction rate and thermal stability between the transformant (25) and the transformant (22), it was found that mutation of 4th Val in the β-subunit with Met was newly added to the transformant (25), so that the initial reaction rate was improved by 1.25 times and thermal stability was improved by 1.25 times, as compared to those of the transformant (22).

	TABLE 9
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-4th	β-4th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
23	α-6th	Leu	Ala	CTG	GCG	1.25 times	1.35 times
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-4th	Val	Met	GTG	ATG
	β-127th	Leu	Ser	CTG	TCG
	β-160th	Arg	Trp	CGG	TGG
	β-186th	Leu	Arg	CTG	CGG
24	α-36th	Thr	Gly	ACG	GGG	1.32 times	1.39 times
	α-188th	Thr	Gly	ACC	GGC
	β-4th	Val	Met	GTG	ATG
25	β-4th	Val	Met	GTG	ATG	1.25 times	1.25 times
	β-176th	Tyr	Ala	TAC	GCC
	β-217th	Asp	Val	GAC	GTC

Reference Example 13

Construction of a Transformant (26) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (26) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ao) amino acid substitution sites as shown in Table 10, the plasma described in Example 72 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (26) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (26).

Reference Example 14

Construction of a Transformant (27) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (27) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (at) amino acid substitution sites as shown in Table 10, the plasma described in Example 77 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (27) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (27).

TABLE 10
		Change in Amino Acid	Change in
Trans-		Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
26	β-127th	Leu	Ser	CTG	TCG
	β-160th	Arg	Trp	CGG	TGG
	β-186th	Leu	Arg	CTG	CGG
27	α-19th	Ala	Val	GCG	GTG
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-37th	Phe	Leu	TTC	CTC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG

Comparative Example 1

Construction of a Transformant (28) Substituted Amino Acid Having Improved Nitrile Hydratase Activity

In order to obtain a transformant (28) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at 8th of the β-subunit and (ao) amino acid substitution sites as shown in Table 11, the plasmid (26) recovered from the transformant (26) described in the above Reference Example 13 was used as the template, and the primer having the sequence defined in SEQ ID No: 30 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (28) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (28). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (28) had sequences according to the purpose in which mutation of 8th Gly in the β-subunit with Ala was newly added to the plasmid (26) of Reference Example 13. In the production of an amide compound using the thus obtained transformant (28) and the transformant (26) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result of comparison, it was found that mutation of 8th Gly in the β-subunit with Ala was newly added to the transformant (28), so that the initial reaction rate was improved by 1.35 times and thermal stability was lowered by 0.65 times, as compared to those of the transformant (26).

Comparative Example 2

Construction of a Transformant (29) Substituted Amino Acid Having Improved Nitrile Hydratase Activity

In order to obtain a transformant (29) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at 8th of the β-subunit and (at) amino acid substitution sites as shown in Table 11, the plasmid (27) recovered from the transformant (27) described in the above Reference Example 14 was used as the template, and the primer having the sequence defined in SEQ ID No: 30 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (29) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (29). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (29) had sequences according to the purpose in which mutation of 8th Gly in the β-subunit with Ala was newly added to the plasmid (27) of Reference Example 14. In the production of an amide compound using the thus obtained transformant (29) and the transformant (27) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 8th Gly in the β-subunit with Ala was newly added to the transformant (29), so that the initial reaction rate was improved by 1.40 times and thermal stability was lowered by 0.31 times, as compared to those of the transformant (27).

Comparative Example 3

Construction of a Transformant (30) Substituted Amino Acid Having Improved Nitrile Hydratase Activity

In order to obtain a transformant (30) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at 8th of the β-subunit and (br) amino acid substitution sites as shown in Table 11, the plasmid (16) recovered from the transformant (16) described in the above Reference Example 9 was used as the template, and the primer having the sequence defined in SEQ ID No: 30 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (30) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (30). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (30) had sequences according to the purpose in which mutation of 8th Gly in the β-subunit with Ala was newly added to the plasmid (16) of Reference Example 9. In the production of an amide compound using the thus obtained transformant (30) and the transformant (16) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 8th Gly in the β-subunit with Ala was newly added to the transformant (30), so that the initial reaction rate was improved by 1.32 times and thermal stability was lowered by 0.52 times, as compared to those of the transformant (16).

	TABLE 11
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-8th	β-8th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
28	α-8th	Gly	Ala	GGC	GCC	1.35 times	0.65 times
	β-127th	Leu	Ser	CTG	TCG
	β-160h	Arg	Trp	CGG	TGG
	β-186th	Leu	Arg	CTG	CGG
29	α-19th	Ala	Val	GCG	GTG	1.40 times	0.31 times
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-8th	Gly	Ala	GGC	GCC
	β-37th	Phe	Leu	TTC	CTC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
30	β-8th	Gly	Ala	GGC	GCC	1.32 times	0.52 times
	β-160th	Arg	Cys	CGG	TGT
	β-168th	Thr	Glu	ACG	GAG

Reference Example 15

Construction of a Transformant (31) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (31) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (au) amino acid substitution sites as shown in Table 12, the plasma described in Example 78 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (31) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (31).

Reference Example 16

Construction of a Transformant (32) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (32) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bf) amino acid substitution sites as shown in Table 12, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 31 and 32 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (32) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (32).

TABLE 12
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
31	α-19th	Ala	Val	GCG	GTG
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-37th	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
32	β-33rd	Ala	Met	GCG	ATG
	β-176th	Tyr	Thr	TAC	ACC

Example 14

Construction of a Transformant (33) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (33) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (f) and (au) amino acid substitution sites as shown in Table 13, the plasmid (31) recovered from the transformant (31) described in the above Reference Example 15 was used as the template, and the primer having the sequence defined in SEQ ID No: 33 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (33) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (33). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (33) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn was newly added to the plasmid (31) of Reference Example 15. In the production of an amide compound using the thus obtained transformant (33) and the transformant (31) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn was newly added to the transformant (33), so that the initial reaction rate was improved by 1.29 times and thermal stability was improved by 1.82 times, as compared to those of the transformant (31).

Example 15

Construction of a Transformant (34) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (34) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (f) and (bf) amino acid substitution sites as shown in Table 13, the plasmid (32) recovered from the transformant (32) described in the above Reference Example 16 was used as the template, and the primer having the sequence defined in SEQ ID No: 33 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (34) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (34). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (34) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn was newly added to the plasmid (32) of Reference Example 16. In the production of an amide compound using the thus obtained transformant (34) and the transformant (32) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn was newly added to the transformant (34), so that the initial reaction rate was improved by 1.25 times and thermal stability was improved by 1.76 times, as compared to those of the transformant (32).

Example 16

Construction of a Transformant (35) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (35) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (f) and (bp) amino acid substitution sites as shown in Table 13, the plasmid (10) recovered from the transformant (10) described in the above Reference Example 6 was used as the template, and the primer having the sequence defined in SEQ ID No: 33 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (35) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (35). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (35) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn was newly added to the plasmid (10) of Reference Example 6. In the production of an amide compound using the thus obtained transformant (35) and the transformant (10) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn was newly added to the transformant (35), so that the initial reaction rate was improved by 1.30 times and thermal stability was improved by 1.72 times, as compared to those of the transformant (10).

	TABLE 13
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-79th	β-79th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
33	α-19th	Ala	Val	GCG	GTG	1.29 times	1.82 times
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-37th	Phe	Val	TTC	GTC
	β-79th	His	Asn	CAC	AAC
	β-108h	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
34	β-33rd	Ala	Met	GCG	ATG	1.25 times	1.76 times
	β-79th	His	Asn	CAC	AAC
	β-176th	Tyr	Thr	TAC	ACC
35	β-61st	Ala	Gly	GCC	GGC	1.30 times	1.72 times
	β-79th	His	Asn	CAC	AAC
	β-150th	Ala	Asn	GCG	AAT

Reference Example 17

Construction of a Transformant (36) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (36) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (aa) amino acid substitution sites as shown in Table 14, the plasma described in Example 58 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (36) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (36).

Reference Example 18

Construction of a Transformant (37) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (37) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ah) amino acid substitution sites as shown in Table 14, the plasma described in Example 65 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (37) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (37).

Reference Example 19

Construction of a Transformant (38) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (38) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (aq) amino acid substitution sites as shown in Table 14, the plasma described in Example 74 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (38) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (38).

TABLE 14
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
36	α-36th	Thr	Met	ACG	ATG
	α-126th	Phe	Tyr	TTC	TAC
37	α-36th	Thr	Met	ACG	ATG
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
38	α-6th	Leu	Thr	CTG	ACG
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-48th	Leu	Val	CTG	GTG
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC

Example 17

Construction of a Transformant (39) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (39) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (g) and (aa) amino acid substitution sites as shown in Table 15, the plasmid (36) recovered from the transformant (36) described in the above Reference Example 17 was used as the template, and the primer having the sequence defined in SEQ ID No: 34 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (39) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (39). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (39) had sequences according to the purpose in which mutation of 96th Gln in the β-subunit with Arg was newly added to the plasmid (36) of Reference Example 17. In the production of an amide compound using the thus obtained transformant (39) and the transformant (36) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 96th Gln in the β-subunit with Arg was newly added to the transformant (39), so that the initial reaction rate was improved by 1.33 times and thermal stability was improved by 1.25 times, as compared to those of the transformant (36).

Example 18

Construction of a Transformant (40) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (40) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (g) and (ah) amino acid substitution sites as shown in Table 15, the plasmid (37) recovered from the transformant (37) described in the above Reference Example 18 was used as the template, and the primer having the sequence defined in SEQ ID No: 34 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (40) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (40). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (40) had sequences according to the purpose in which mutation of 96th Gln in the β-subunit with Arg was newly added to the plasmid (37) of Reference Example 18. In the production of an amide compound using the thus obtained transformant (40) and the transformant (37) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 96th Gln in the β-subunit with Arg was newly added to the transformant (40), so that the initial reaction rate was improved by 1.25 times and thermal stability was improved by 1.36 times, as compared to those of the transformant (37).

Example 19

Construction of a Transformant (41) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (41) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (g) and (aq) amino acid substitution sites as shown in Table 15, the plasmid (38) recovered from the transformant (38) described in the above Reference Example 19 was used as the template, and the primer having the sequence defined in SEQ ID No: 34 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (41) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (41). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (41) had sequences according to the purpose in which mutation of 96th Gln in the β-subunit with Arg was newly added to the plasmid (38) of Reference Example 19. In the production of an amide compound using the thus obtained transformant (41) and the transformant (38) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 96th Gln in the β-subunit with Arg was newly added to the transformant (41), so that the initial reaction rate was improved by 1.35 times and thermal stability was improved by 1.42 times, as compared to those of the transformant (38).

	TABLE 15
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-96th	β-96th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
39	α-36th	Thr	Met	ACG	ATG	1.33 times	1.25 times
	α-126th	Phe	Tyr	TTC	TAC
	β-96th	Gln	Arg	CAG	CGT
40	α-36th	Thr	Met	ACG	ATG	1.25 times	1.36 times
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-96th	Gln	Arg	CAG	CGT
41	α-6th	Leu	Thr	CTG	ACG	1.35 times	1.42 times
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-48th	Leu	Val	CTG	GTG
	β-96th	Gln	Arg	CAG	CGT
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC

Reference Example 20

Construction of a Transformant (42) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (42) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ae) amino acid substitution sites as shown in Table 16, the plasma described in Example 62 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (42) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (42).

Reference Example 21

Construction of a Transformant (43) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (43) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bk) amino acid substitution sites as shown in Table 16, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 35 and 36 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (43) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (43).

TABLE 16
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
42	β-160th	Arg	Trp	CGG	TGG
	β-186th	Leu	Arg	CTG	CGG
43	β-61st	Ala	Trp	GCC	TGG
	β-217th	Asp	His	GAC	CAC

Example 20

Construction of a Transformant (44) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (44) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (h) and (ae) amino acid substitution sites as shown in Table 17, the plasmid (42) recovered from the transformant (42) described in the above Reference Example 20 was used as the template, and the primer having the sequence defined in SEQ ID No: 37 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (44) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (44). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (44) had sequences according to the purpose in which mutation of 107th Pro in the β-subunit with Met was newly added to the plasmid (42) of Reference Example 20. In the production of an amide compound using the thus obtained transformant (44) and the transformant (42) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 107th Pro in the β-subunit with Met was newly added to the transformant (44), so that the initial reaction rate was improved by 1.34 times and thermal stability was improved by 2.25 times, as compared to those of the transformant (42).

Example 21

Construction (45) of a Transformant (45) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (45) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (h) and (au) amino acid substitution sites as shown in Table 17, the plasmid (31) recovered from the transformant (31) described in the above Reference Example 15 was used as the template, and the primer having the sequence defined in SEQ ID No: 68 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (45) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (45). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (45) had sequences according to the purpose in which mutation of 107th Pro in the β-subunit with Met was newly added to the plasmid (31) of Reference Example 15. In the production of an amide compound using the thus obtained transformant (45) and the transformant (31) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 107th Pro in the β-subunit with Met was newly added to the transformant (45), so that the initial reaction rate was improved by 1.40 times and thermal stability was improved by 2.12 times, as compared to those of the transformant (31).

Example 22

Construction of a Transformant (46) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (46) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (h) and (bk) amino acid substitution sites as shown in Table 17, the plasmid (43) recovered from the transformant (43) described in the above Reference Example 21 was used as the template, and the primer having the sequence defined in SEQ ID No: 37 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (46) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (46). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (46) had sequences according to the purpose in which mutation of 107th Pro in the β-subunit with Met was newly added to the plasmid (43) of Reference Example 21. In the production of an amide compound using the thus obtained transformant (46) and the transformant (43) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 107th Pro in the β-subunit with Met was newly added to the transformant (46), so that the initial reaction rate was improved by 1.32 times and thermal stability was improved by 2.40 times, as compared to those of the transformant (43).

	TABLE 17
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-107th	β-107th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
44	β-107th	Pro	Met	CCC	ATG	1.34 times	2.25 times
	β-160th	Arg	Trp	CGG	TGG
	β-186th	Leu	Arg	CTG	CGG
45	α-19th	Ala	Val	GCG	GTG	1.40 times	2.12 times
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-37th	Phe	Val	TTC	GTC
	β-107th	Pro	Met	CCC	ATG
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
46	β-61st	Ala	Trp	GCC	TGG	1.32 times	2.40 times
	β-107th	Pro	Met	CCC	ATG
	β-217th	Asp	His	GAC	CAC

Example 23

Construction of a Transformant (47) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (47) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (i) and (aa) amino acid substitution sites as shown in Table 18, the plasmid (36) recovered from the transformant (36) described in the above Reference Example 17 was used as the template, and the primer having the sequence defined in SEQ ID No: 38 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (47) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (47). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (47) had sequences according to the purpose in which mutation of 226th Val in the β-subunit with Ile was newly added to the plasmid (36) of Reference Example 17. In the production of an amide compound using the thus obtained transformant (47) and the transformant (36) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 226th Val in the β-subunit with Ile was newly added to the transformant (47), so that the initial reaction rate was improved by 1.26 times and thermal stability was improved by 1.29 times, as compared to those of the transformant (36).

Example 24

Construction (48) of a Transformant (48) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (48) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (i) and (ak) amino acid substitution sites as shown in Table 18, the plasmid (8) recovered from the transformant (8) described in the above Reference Example 4 was used as the template, and the primer having the sequence defined in SEQ ID No: 38 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (48) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (48). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (48) had sequences according to the purpose in which mutation of 226th Val in the β-subunit with Ile was newly added to the plasmid (8) of Reference Example 4. In the production of an amide compound using the thus obtained transformant (48) and the transformant (8) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 226th Val in the β-subunit with Ile was newly added to the transformant (48), so that the initial reaction rate was improved by 1.35 times and thermal stability was improved by 1.27 times, as compared to those of the transformant (8).

Example 25

Construction of a Transformant (49) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (49) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (i) and (be) amino acid substitution sites as shown in Table 18, the plasmid (15) recovered from the transformant (15) described in the above Reference Example 8 was used as the template, and the primer having the sequence defined in SEQ ID No: 38 in the Sequence Listing was used for carrying out the method using the mutagenesis kit described in Reference Example 2, whereby a plasmid (49) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (49). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (49) had sequences according to the purpose in which mutation of 226th Val in the β-subunit with Ile was newly added to the plasmid (15) of Reference Example 8. In the production of an amide compound using the thus obtained transformant (49) and the transformant (15) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 226th Val in the β-subunit with Ile was newly added to the transformant (49), so that the initial reaction rate was improved by 1.25 times and thermal stability was improved by 1.30 times, as compared to those of the transformant (15).

	TABLE 18
	Change in Amino Acid	Change in Base		Improvement of
	Sequence	Sequence	Improvement of	Thermal
Trans-		Before	After	Before	After	Reaction Rate by	Stability by
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-226th	β-226th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
47	α-36th	Thr	Met	ACG	ATG	1.26 times	1.29 times
	α-126th	Phe	Tyr	TTC	TAC
	β-226th	Val	Ile	GTC	ATC
48	β-37th	Phe	Val	TTC	GTC	1.35 times	1.27 times
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
	β-226th	Val	Ile	GTC	ATC
49	β-40th	Thr	Val	ACG	GTG	1.25 times	1.30 times
	β-218th	Cys	Met	TGC	ATG
	β-226th	Val	Ile	GTC	ATC

Reference Example 22

Construction of a Transformant (50) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (50) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (af) amino acid substitution sites as shown in Table 19, the plasma described in Example 63 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (50) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (50).

Reference Example 23

Construction of a Transformant (51) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a plasmid encoding the nitrile hydratase variant obtained by mutating nitrile hydratase at (bq) amino acid substitution sites as shown in Table 19, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, the primers having the sequence defined in SEQ ID Nos: 39 and 40 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (51) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (51).

Reference Example 24

Construction of a Transformant (52) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (52) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bj) amino acid substitution sites as shown in Table 19, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 41 and 42 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (52) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (52).

TABLE 19
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
50	α-6th	Leu	Thr	CTG	ACG
	α-36th	Thr	Met	ACG	ATG
	α-126th	Phe	Tyr	TTC	TAC
51	β-61st	Ala	Ser	GCC	TCG
	β-160th	Arg	Met	CGG	ATG
52	β-112th	Lys	Val	AAG	GTG
	β-217th	Asp	Met	GAC	ATG

Example 26

Construction of a Transformant (53) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (53) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (m−1) and (af) amino acid substitution sites as shown in Table 20, the plasmid (50) recovered from the transformant (50) described in the above Reference Example 22 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43 and 19 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (53) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (53). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (53) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu and mutation of 94th Met in the α-subunit with Ile were newly added to the plasmid (50) of Reference Example 22. In the production of an amide compound using the thus obtained transformant (53) and the transformant (50) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu and mutation of 94th Met in the α-subunit with Ile were newly added to the transformant (53), so that the initial reaction rate was improved by 1.67 times and thermal stability was improved by 1.45 times, as compared to those of the transformant (50).

Example 27

Construction of a Transformant (54) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (54) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (m−1) and (bq) amino acid substitution sites as shown in Table 20, the plasmid (51) recovered from the transformant (51) described in the above Reference Example 23 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43 and 19 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (54) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (54). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (54) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu and mutation of 94th Met in the α-subunit with Ile were newly added to the plasmid (51) of Reference Example 23. In the production of an amide compound using the thus obtained transformant (54) and the transformant (51) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu and mutation of 94th Met in the α-subunit with Ile were newly added to the transformant (54), so that the initial reaction rate was improved by 1.59 times and thermal stability was improved by 1.32 times, as compared to those of the transformant (51).

Example 28

Construction of a Transformant (55) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (55) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (m−1) and (bj) amino acid substitution sites as shown in Table 20, the plasmid (52) recovered from the transformant (52) described in the above Reference Example 24 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43 and 19 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (55) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (55). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (55) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu and mutation of 94th Met in the α-subunit with Ile were newly added to the plasmid (52) of Reference Example 24. In the production of an amide compound using the thus obtained transformant (55) and the transformant (52) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu and mutation of 94th Met in the α-subunit with Ile were newly added to the transformant (55), so that the initial reaction rate was improved by 1.62 times and thermal stability was improved by 1.26 times, as compared to those of the transformant (52).

	TABLE 20
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-13th and	α-13th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	α-94th	α-94th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
53	α-6th	Leu	Thr	CTG	ACG	1.67 times	1.45 times
	α-13th	Ile	Leu	ATC	CTC
	α-36th	Thr	Met	ACG	ATG
	α-94th	Met	Ile	ATG	ATC
	α-126th	Phe	Tyr	TTC	TAC
54	α-13th	Ile	Leu	ATC	CTC	1.59 times	1.32 times
	α-94th	Met	Ile	ATG	ATC
	β-61st	Ala	Ser	GCC	TCG
	β-160th	Arg	Met	CGG	ATG
55	α-13th	Ile	Leu	ATC	CTC	1.62 times	1.26 times
	α-94th	Met	Ile	ATG	ATC
	β-112th	Lys	Val	AAG	GTG
	β-217th	Asp	Met	GAC	ATG

Reference Example 25

Construction of a Transformant (56) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (56) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (am) amino acid substitution sites as shown in Table 21, the plasma described in Example 70 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (56) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (56).

Reference Example 26

Construction of a Transformant (57) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (57) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ay) amino acid substitution sites as shown in Table 21, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 44 and 45 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (57) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (57).

TABLE 21
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
56	β-46th	Met	Lys	ATG	AAG
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
57	α-36th	Thr	Ala	ACG	GCG
	α-48th	Asn	Gln	AAC	CAA

Example 29

Construction of a Transformant (58) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (58) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (m-2) and (am) amino acid substitution sites as shown in Table 22, the plasmid (56) recovered from the transformant (56) described in the above Reference Example 25 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43 and 34 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (58) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (58). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (56) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu and mutation of 96th Gln in the β-subunit with Arg were newly added to the plasmid (56) of Reference Example 25. In the production of an amide compound using the thus obtained transformant (58) and the transformant (56) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu and mutation of 96th Gln in the β-subunit with Arg were newly added to the transformant (58), so that the initial reaction rate was improved by 1.53 times and thermal stability was improved by 1.32 times, as compared to those of the transformant (56).

Example 30

Construction of a Transformant (59) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (59) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (m-2) and (at) amino acid substitution sites as shown in Table 22, the plasmid (27) recovered from the transformant (27) described in the above Reference Example 14 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43 and 34 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (59) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (59). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (59) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu and mutation of 96th Gln in the β-subunit with Arg were newly added to the plasmid (27) of Reference Example 14. In the production of an amide compound using the thus obtained transformant (59) and the transformant (27) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu and mutation of 96th Gln in the β-subunit with Arg were newly added to the transformant (59), so that the initial reaction rate was improved by 1.49 times and thermal stability was improved by 1.28 times, as compared to those of the transformant (27).

Example 31

Construction of a Transformant (60) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (60) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (m-2) and (ay) amino acid substitution sites as shown in Table 22, the plasmid (57) recovered from the transformant (57) described in the above Reference Example 26 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43 and 34 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (60) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (60). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (60) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu and mutation of 96th Gln in the β-subunit with Arg were newly added to the plasmid (57) of Reference Example 26. In the production of an amide compound using the thus obtained transformant (60) and the transformant (57) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu and mutation of 96th Gln in the β-subunit with Arg were newly added to the transformant (60), so that the initial reaction rate was improved by 1.39 times and thermal stability was improved by 1.45 times, as compared to those of the transformant (57).

	TABLE 22
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-13th and	α-13th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-96th	β-96th
No.	Site	tion	tion	tion	tion	Substitutions	Substitutions
58	α-13th	Ile	Leu	ATC	CTC	1.53 times	1.32 times
	β-46th	Met	Lys	ATG	AAG
	β-96th	Gln	Arg	CAG	CGT
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
59	α-13th	Ile	Leu	ATC	CTC	1.49 times	1.28 times
	α-19th	Ala	Val	GCG	GTG
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-37th	Phe	Leu	TTC	CTC
	β-96th	Gln	Arg	CAG	CGT
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
60	α-13th	Ile	Leu	ATC	CTC	1.39 times	1.45 times
	α-36th	Thr	Ala	ACG	GCG
	α-48th	Asn	Gln	AAC	CAA
	β-96th	Gln	Arg	CAG	CGT

Example 32

Construction of a Transformant (61) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (61) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (n−1) and (af) amino acid substitution sites as shown in Table 23, the plasmid (50) recovered from the transformant (50) described in the above Reference Example 22 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 46 and 19 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (61) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (61). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (61) had sequences according to the purpose in which mutation of 27th Met in the α-subunit with Ile and mutation of 94th Met in the α-subunit with Ile were newly added to the plasmid (50) of Reference Example 22. In the production of an amide compound using the thus obtained transformant (61) and the transformant (50) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 27th Met in the α-subunit with Ile and mutation of 94th Met in the α-subunit with Ile were newly added to the transformant (61), so that the initial reaction rate was improved by 1.65 times and thermal stability was improved by 1.36 times, as compared to those of the transformant (50).

Example 33

Construction of a Transformant (62) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (62) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (n−1) and (ao) amino acid substitution sites as shown in Table 23, the plasmid (26) recovered from the transformant (26) described in the above Reference Example 13 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 46 and 19 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (62) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (62). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (62) had sequences according to the purpose in which mutation of 27th Met in the α-subunit with Ile and mutation of 94th Met in the α-subunit with Ile were newly added to the plasmid (26) of Reference Example 13. In the production of an amide compound using the thus obtained transformant (62) and the transformant (26) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 27th Met in the α-subunit with Ile and mutation of 94th Met in the α-subunit with Ile were newly added to the transformant (62), so that the initial reaction rate was improved by 1.72 times and thermal stability was improved by 1.47 times, as compared to those of the transformant (26).

Example 34

Construction of a Transformant (63) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (63) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (n−1) and (ax) amino acid substitution sites as shown in Table 23, the plasmid (21) recovered from the transformant (21) described in the above Reference Example 11 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 46 and 19 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (63) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (63). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (63) had sequences according to the purpose in which mutation of 27th Met in the α-subunit with Ile and mutation of 94th Met in the α-subunit with Ile were newly added to the plasmid (21) of Reference Example 11. In the production of an amide compound using the thus obtained transformant (63) and the transformant (21) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 27th Met in the α-subunit with Ile and mutation of 94th Met in the α-subunit with Ile were newly added to the transformant (63), so that the initial reaction rate was improved by 1.55 times and thermal stability was improved by 1.27 times, as compared to those of the transformant (21).

	TABLE 23
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-27th and	α-27th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	α-94th	α-94th
No.	Site	tion	tion	tion	tion	Substitutions	Substitutions
61	α-6th	Leu	Thr	CTG	ACG	1.65 times	1.36 times
	α-27th	Met	Ile	ATG	ATC
	α-36th	Thr	Met	ACG	ATG
	α-94th	Met	Ile	ATG	ATC
	α-126th	Phe	Tyr	TTC	TAC
62	α-27th	Met	Ile	ATG	ATC	1.72 times	1.47 times
	α-94th	Met	Ile	ATG	ATC
	β-127th	Leu	Ser	CTG	TCG
	β-160th	Arg	Trp	CGG	TGG
	β-186th	Leu	Arg	CTG	CGG
63	α-27th	Met	Ile	ATG	ATC	1.55 times	1.27 times
	α-36th	Thr	Gly	ACG	GGG
	α-94th	Met	Ile	ATG	ATC
	α-188th	Thr	Gly	ACC	GGC

Reference Example 27

Construction of a Transformant (64) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (64) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (aj) amino acid substitution sites as shown in Table 24, the plasma described in Example 67 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (64) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (64).

Reference Example 28

Construction of a Transformant (65) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (65) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (as) amino acid substitution sites as shown in Table 24, the plasma described in Example 76 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (65) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (65).

Reference Example 29

Construction of a Transformant (66) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (66) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bb) amino acid substitution sites as shown in Table 24, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 47 and 48 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (66) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (66).

TABLE 24
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
64	β-37th	Phe	Leu	TTC	CTC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
65	α-6th	Leu	Thr	CTG	ACG
	α-36th	Thr	Met	ACG	ATG
	α-126th	Phe	Tyr	TTC	TAC
	β-10th	Thr	Asp	ACC	GAC
	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG
66	β-176th	Tyr	Met	TAC	ATG
	β-217th	Asp	Gly	GAC	GGC

Example 35

Construction of a Transformant (67) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (67) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (n-2) and (aj) amino acid substitution sites as shown in Table 25, the plasmid (64) recovered from the transformant (64) described in the above Reference Example 27 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 46 and 68 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (67) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (67). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (67) had sequences according to the purpose in which mutation of 27th Met in the α-subunit with Ile and mutation of 107th Pro in the β-subunit with Met were newly added to the plasmid (64) of Reference Example 27. In the production of an amide compound using the thus obtained transformant (67) and the transformant (64) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 27th Met in the α-subunit with Ile and mutation of 107th Pro in the β-subunit with Met were newly added to the transformant (67), so that the initial reaction rate was improved by 1.53 times and thermal stability was improved by 2.23 times, as compared to those of the transformant (64).

Example 36

Construction of a Transformant (68) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (68) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (n-2) and (as) amino acid substitution sites as shown in Table 25, the plasmid (65) recovered from the transformant (65) described in the above Reference Example 28 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 46 and 37 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (68) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (68). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (68) had sequences according to the purpose in which mutation of 27th Met in the α-subunit with Ile and mutation of 107th Pro in the β-subunit with Met were newly added to the plasmid (65) of Reference Example 28. In the production of an amide compound using the thus obtained transformant (68) and the transformant (65) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 27th Met in the α-subunit with Ile and mutation of 107th Pro in the β-subunit with Met were newly added to the transformant (68), so that the initial reaction rate was improved by 1.55 times and thermal stability was improved by 2.15 times, as compared to those of the transformant (65).

Example 37

Construction of a Transformant (69) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (69) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (n-2) and (bb) amino acid substitution sites as shown in Table 25, the plasmid (66) recovered from the transformant (66) described in the above Reference Example 29 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 46 and 37 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (69) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (69). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (69) had sequences according to the purpose in which mutation of 27th Met in the α-subunit with Ile and mutation of 107th Pro in the β-subunit with Met were newly added to the plasmid (66) of Reference Example 29. In the production of an amide compound using the thus obtained transformant (69) and the transformant (66) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 27th Met in the α-subunit with Ile and mutation of 107th Pro in the β-subunit with Met were newly added to the transformant (69), so that the initial reaction rate was improved by 1.46 times and thermal stability was improved by 1.92 times, as compared to those of the transformant (66).

	TABLE 25
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-27th and	α-27th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-107th	β-107th
No.	Site	tion	tion	tion	tion	Substitutions	Substitutions
67	α-27th	Met	Ile	ATG	ATC	1.53 times	2.23 times
	β-37th	Phe	Leu	TTC	CTC
	β-107th	Pro	Met	CCC	ATG
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
68	α-6th	Leu	Thr	CTG	ACG	1.55 times	2.15 times
	α-27th	Met	Ile	ATG	ATC
	α-36th	Thr	Met	ACG	ATG
	α-126th	Phe	Tyr	TTC	TAC
	β-10th	Thr	Asp	ACC	GAC
	β-107th	Pro	Met	CCC	ATG
	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG
69	α-27th	Met	Ile	ATG	ATC	1.46 times	1.92 times
	β-107th	Pro	Met	CCC	ATG
	β-176th	Tyr	Met	TAC	ATG
	β-217th	Asp	Gly	GAC	GGC

Reference Example 30

Construction of a Transformant (70) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (70) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (al) amino acid substitution sites as shown in Table 26, the plasma described in Example 69 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (70) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (70).

Reference Example 31

Construction of a Transformant (71) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (71) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (aw) amino acid substitution sites as shown in Table 26, the plasma described in Example 80 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (71) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (71).

Reference Example 32

Construction of a Transformant (72) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (72) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bl) amino acid substitution sites as shown in Table 26, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 49 and 50 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (72) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (72).

TABLE 26
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
70	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
71	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
72	β-61st	Ala	Leu	GCC	CTC
	β-112th	Lys	Ile	AAG	ATT

Example 38

Construction of a Transformant (73) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (73) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (q) and (al) amino acid substitution sites as shown in Table 27, the plasmid (70) recovered from the transformant (70) described in the above Reference Example 30 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 16 and 38 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (73) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (73). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (73) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu and mutation of 226th Val in the β-subunit with Ile were newly added to the plasmid (70) of Reference Example 30. In the production of an amide compound using the thus obtained transformant (73) and the transformant (70) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu and mutation of 226th Val in the β-subunit with Ile were newly added to the transformant (73), so that the initial reaction rate was improved by 2.00 times and thermal stability was improved by 1.52 times, as compared to those of the transformant (70).

Example 39

Construction of a Transformant (74) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (74) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (q) and (aw) amino acid substitution sites as shown in Table 27, the plasmid (71) recovered from the transformant (71) described in the above Reference Example 31 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 16 and 38 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (74) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (74). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (74) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu and mutation of 226th Val in the β-subunit with Ile were newly added to the plasmid (71) of Reference Example 31. In the production of an amide compound using the thus obtained transformant (74) and the transformant (71) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu and mutation of 226th Val in the β-subunit with Ile were newly added to the transformant (74), so that the initial reaction rate was improved by 1.78 times and thermal stability was improved by 1.44 times, as compared to those of the transformant (71).

Example 40

Construction of a Transformant (75) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (75) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (q) and (bl) amino acid substitution sites as shown in Table 27, the plasmid (72) recovered from the transformant (72) described in the above Reference Example 32 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 16 and 38 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (75) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (75). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (75) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu and mutation of 226th Val in the β-subunit with Ile were newly added to the plasmid (72) of Reference Example 32. In the production of an amide compound using the thus obtained transformant (75) and the transformant (72) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu and mutation of 226th Val in the β-subunit with Ile were newly added to the transformant (75), so that the initial reaction rate was improved by 1.85 times and thermal stability was improved by 1.38 times, as compared to those of the transformant (72).

	TABLE 27
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-92nd and	α-92nd and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-226th	β-226th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
73	α-92nd	Asp	Glu	GAC	GAG	2.00 times	1.52 times
	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
	β-226th	Val	Ile	GTC	ATC
74	α-92nd	Asp	Glu	GAC	GAG	1.78 times	1.44 times
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-108th	Glu	Asp	GAG	GAT
	β-200th	Ala	Glu	GCC	GAG
	β-226th	Val	Ile	GTC	ATC
75	α-92nd	Asp	Glu	GAC	GAG	1.85 times	1.38 times
	β-61st	Ala	Leu	GCC	CTC
	β-112th	Lys	Ile	AAG	ATT
	β-226th	Val	Ile	GTC	ATC

Reference Example 33

Construction of a Transformant (76) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (76) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bi) amino acid substitution sites as shown in Table 28, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 51 and 52 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (76) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (76).

Reference Example 34

Construction of a Transformant (77) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (77) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bm) amino acid substitution sites as shown in Table 28, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 53 and 54 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (77) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (77).

TABLE 28
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
76	β-61st	Ala	Thr	GCC	ACG
	β-218th	Cys	Ser	TGC	TCC
77	β-146th	Arg	Gly	CGG	GGG
	β-217th	Asp	Ser	GAC	AGC

Example 41

Construction of a Transformant (78) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (78) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (o) and (an) amino acid substitution sites as shown in Table 29, the plasmid (14) recovered from the transformant (14) described in the above Reference Example 7 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 29 and 33 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (78) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (78). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (78) had sequences according to the purpose in which mutation of 4th Val in the β-subunit with Met and mutation of 79th His in the β-subunit with Asn were newly added to the plasmid (14) of Reference Example 7. In the production of an amide compound using the thus obtained transformant (78) and the transformant (14) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 4th Val in the β-subunit with Met and mutation of 79th His in the β-subunit with Asn were newly added to the transformant (78), so that the initial reaction rate was improved by 1.60 times and thermal stability was improved by 1.46 times, as compared to those of the transformant (14).

Example 42

Construction of a Transformant (79) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (79) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (o) and (bi) amino acid substitution sites as shown in Table 29, the plasmid (76) recovered from the transformant (76) described in the above Reference Example 33 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 29 and 33 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (79) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (79). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (79) had sequences according to the purpose in which mutation of 4th Val in the β-subunit with Met and mutation of 79th His in the β-subunit with Asn were newly added to the plasmid (76) of Reference Example 33. In the production of an amide compound using the thus obtained transformant (79) and the transformant (76) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 4th Val in the β-subunit with Met and mutation of 79th His in the β-subunit with Asn were newly added to the transformant (79), so that the initial reaction rate was improved by 1.38 times and thermal stability was improved by 1.35 times, as compared to those of the transformant (76).

Example 43

Construction of a Transformant (80) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (80) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (o) and (bm) amino acid substitution sites as shown in Table 29, the plasmid (77) recovered from the transformant (77) described in the above Reference Example 34 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 29 and 33 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (80) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (80). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (80) had sequences according to the purpose in which mutation of 4th Val in the β-subunit with Met and mutation of 79th His in the β-subunit with Asn were newly added to the plasmid (77) of Reference Example 34. In the production of an amide compound using the thus obtained transformant (80) and the transformant (77) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 4th Val in the β-subunit with Met and mutation of 79th His in the β-subunit with Asn were newly added to the transformant (80), so that the initial reaction rate was improved by 1.52 times and thermal stability was improved by 1.28 times, as compared to those of the transformant (77).

	TABLE 29
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	β-4th and	β-4th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-79th	β-79th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
78	β-4th	Val	Met	GTG	ATG	1.60 times	1.46 times
	β-48th	Leu	Val	CTG	GTG
	β-79th	His	Asn	CAC	AAC
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
79	β-4th	Val	Met	GTG	ATG	1.38 times	1.35 times
	β-61st	Ala	Thr	GCC	ACG
	β-79th	His	Asn	CAC	AAC
	β-218th	Cys	Ser	TGC	TCC
80	β-4th	Val	Met	GTG	ATG	1.52 times	1.28 times
	β-79th	His	Asn	CAC	AAC
	β-146th	Arg	Gly	CGG	GGG
	β-217th	Asp	Ser	GAC	AGC

Reference Example 35

Construction of a Transformant (81) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (81) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ag) amino acid substitution sites as shown in Table 30, the plasma described in Example 64 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (81) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (81).

Reference Example 36

Construction of a Transformant (82) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (82) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ai) amino acid substitution sites as shown in Table 30, the plasma described in Example 66 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (82) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (82).

TABLE 30
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
81	α-19th	Ala	Val	GCG	GTG
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
82	β-10th	Thr	Asp	ACC	GAC
	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG

Example 44

Construction of a Transformant (83) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (83) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (p) and (ag) amino acid substitution sites as shown in Table 31, the plasmid (81) recovered from the transformant (81) described in the above Reference Example 35 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 33 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (83) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (83). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (83) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (81) of Reference Example 35. In the production of an amide compound using the thus obtained transformant (83) and the transformant (81) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (83), so that the initial reaction rate was improved by 1.25 times and thermal stability was improved by 2.16 times, as compared to those of the transformant (81).

Example 45

Construction of a Transformant (84) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (84) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (p) and (ai) amino acid substitution sites as shown in Table 31, the plasmid (82) recovered from the transformant (82) described in the above Reference Example 36 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 33 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (84) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (84). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (84) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (82) of Reference Example 36. In the production of an amide compound using the thus obtained transformant (84) and the transformant (82) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (84), so that the initial reaction rate was improved by 1.27 times and thermal stability was improved by 2.10 times, as compared to those of the transformant (82).

Example 46

Construction (85) of a Transformant (85) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (85) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (p) and (aq) amino acid substitution sites as shown in Table 31, the plasmid (38) recovered from the transformant (38) described in the above Reference Example 19 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 33 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (85) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (85). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (85) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (38) of Reference Example 31. In the production of an amide compound using the thus obtained transformant (85) and the transformant (38) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (85), so that the initial reaction rate was improved by 1.33 times and thermal stability was improved by 2.52 times, as compared to those of the transformant (38).

	TABLE 31
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	β-79th and	β-79th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-230th	β-230th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
83	α-19th	Ala	Val	GCG	GTG	1.25 times	2.16 times
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-79th	His	Asn	CAC	AAC
	β-230th	Ala	Glu	GCG	GAG
84	β-10th	Thr	Asp	ACC	GAC	1.27 times	2.10 times
	β-79th	His	Asn	CAC	AAC
	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG
	β-230th	Ala	Glu	GCG	GAG
85	α-6th	Leu	Thr	CTG	ACG	1.33 times	2.52 times
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-48th	Leu	Val	CTG	GTG
	β-79th	His	Asn	CAC	AAC
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
	β-230th	Ala	Glu	GCG	GAG

Reference Example 37

Construction of a Transformant (86) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (86) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ad) amino acid substitution sites as shown in Table 32, the plasma described in Example 61 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (86) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (86).

Reference Example 38

Construction of a Transformant (87) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (87) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bg) amino acid substitution sites as shown in Table 32, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 55 and 56 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (87) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (87).

TABLE 32
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
86	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG
87	β-40th	Thr	Leu	ACG	CTG
	β-217th	Asp	Leu	GAC	CTC

Example 47

Construction of a Transformant (88) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (88) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (j) and (ad) amino acid substitution sites as shown in Table 33, the plasmid (86) recovered from the transformant (86) described in the above Reference Example 37 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 57 and 58 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (88) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (88). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (88) had sequences according to the purpose in which mutation of 110th Glu in the β-subunit with Asn and mutation of 231st Ala in the β-subunit with Val were newly added to the plasmid (86) of Reference Example 37. In the production of an amide compound using the thus obtained transformant (88) and the transformant (86) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 110th Glu in the β-subunit with Asn and mutation of 231st Ala in the β-subunit with Val were newly added to the transformant (88), so that the initial reaction rate was improved by 1.29 times and thermal stability was improved by 1.62 times, as compared to those of the transformant (86).

Example 48

Construction of a Transformant (89) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (89) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (j) and (aj) amino acid substitution sites as shown in Table 33, the plasmid (64) recovered from the transformant (64) described in the above Reference Example 27 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 57 and 58 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (89) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (89). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (89) had sequences according to the purpose in which mutation of 110th Glu in the β-subunit with Asn and mutation of 231st Ala in the β-subunit with Val were newly added to the plasmid (64) of Reference Example 27. In the production of an amide compound using the thus obtained transformant (89) and the transformant (64) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 110th Glu in the β-subunit with Asn and mutation of 231st Ala in the β-subunit with Val were newly added to the transformant (89), so that the initial reaction rate was improved by 1.34 times and thermal stability was improved by 1.83 times, as compared to those of the transformant (64).

Example 49

Construction of a Transformant (90) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (90) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (j) and (bg) amino acid substitution sites as shown in Table 33, the plasmid (87) recovered from the transformant (87) described in the above Reference Example 38 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 57 and 58 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (90) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (90). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (90) had sequences according to the purpose in which mutation of 110th Glu in the β-subunit with Asn and mutation of 231st Ala in the β-subunit with Val were newly added to the plasmid (87) of Reference Example 38. In the production of an amide compound using the thus obtained transformant (90) and the transformant (87) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 110th Glu in the β-subunit with Asn and mutation of 231st Ala in the β-subunit with Val were newly added to the transformant (90), so that the initial reaction rate was improved by 1.25 times and thermal stability was improved by 1.46 times, as compared to those of the transformant (87).

	TABLE 33
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	β-110th and	β-110th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-231st	β-231st
No.	Site	tion	tion	tion	tion	Substitution	Substitution
88	β-110th	Glu	Asn	GAG	AAC	1.29 times	1.62 times
	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG
	β-231st	Ala	Val	GCC	GTC
89	β-37th	Phe	Leu	TTC	CTC	1.34 times	1.83 times
	β-108th	Glu	Asp	GAG	GAT
	β-110th	Glu	Asn	GAG	AAC
	β-200th	Ala	Glu	GCC	GAG
	β-231st	Ala	Val	GCC	GTC
90	β-40th	Thr	Leu	ACG	CTG	1.25 times	1.46 times
	β-110th	Glu	Asn	GAG	AAC
	β-217th	Asp	Leu	GAC	CTC
	β-231st	Ala	Val	GCC	GTC

Example 50

Construction of a Transformant (91) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (91) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (k) and (ad) amino acid substitution sites as shown in Table 34, the plasmid (86) recovered from the transformant (86) described in the above Reference Example 37 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 59 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (91) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (91). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (91) had sequences according to the purpose in which mutation of 206th Pro in the β-subunit with Leu and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (86) of Reference Example 37. In the production of an amide compound using the thus obtained transformant (91) and the transformant (86) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 206th Pro in the β-subunit with Leu and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (91), so that the initial reaction rate was improved by 1.44 times and thermal stability was improved by 1.42 times, as compared to those of the transformant (86).

Example 51

Construction of a Transformant (92) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (92) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (k) and (as) amino acid substitution sites as shown in Table 34, the plasmid (65) recovered from the transformant (65) described in the above Reference Example 28 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 59 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (92) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (92). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (92) had sequences according to the purpose in which mutation of 206th Pro in the β-subunit with Leu and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (65) of Reference Example 28. In the production of an amide compound using the thus obtained transformant (92) and the transformant (65) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 206th Pro in the β-subunit with Leu and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (92), so that the initial reaction rate was improved by 1.48 times and thermal stability was improved by 1.39 times, as compared to those of the transformant (65).

Example 52

Construction of a Transformant (93) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (93) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (k) and (av) amino acid substitution sites as shown in Table 34, the plasmid (2) recovered from the transformant (2) described in the above Reference Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 59 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (93) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (93). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (93) had sequences according to the purpose in which mutation of 206th Pro in the β-subunit with Leu and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (2) of Reference Example 1. In the production of an amide compound using the thus obtained transformant (93) and the transformant (2) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 206th Pro in the β-subunit with Leu and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (93), so that the initial reaction rate was improved by 1.36 times and thermal stability was improved by 1.52 times, as compared to those of the transformant (2).

	TABLE 34
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	β-206th and	β-206th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-230th	β-230th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
91	β-118th	Phe	Val	TCC	GTC	1.44 times	1.42 times
	β-200th	Ala	Glu	GCC	GAG
	β-206th	Pro	Leu	CCG	CTG
	β-230th	Ala	Glu	GCG	GAG
92	α-6th	Leu	Thr	CTG	ACG	1.48 times	1.39 times
	α-36th	Thr	Met	ACG	ATG
	α-126th	Phe	Tyr	TTC	TAC
	β-10th	Thr	Asp	ACC	GAC
	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG
	β-206th	Pro	Leu	CCG	CTG
	β-230th	Ala	Glu	GCG	GAG
93	α-36th	Thr	Met	ACG	ATG	1.36 times	1.52 times
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
	β-206th	Pro	Leu	CCG	CTG
	β-230th	Ala	Glu	GCG	GAG

Reference Example 39

Construction of a Transformant (94) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (94) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (bo) amino acid substitution sites as shown in Table 35, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 61 and 62 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (94) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (94).

TABLE 35
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
94	β-150th	Ala	Ser	GCG	TCG
	β-217th	Asp	Cys	GAC	TGT

Example 53

Construction of a Transformant (95) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (95) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (1) and (ag) amino acid substitution sites as shown in Table 36, the plasmid (81) recovered from the transformant (81) described in the above Reference Example 35 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43, 46 and 57 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (95) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (95). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (95) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu, mutation of 27th Met in the α-subunit with Ile and mutation of 110th Glu in the β-subunit with Asn were newly added to the plasmid (81) of Reference Example 35. In the production of an amide compound using the thus obtained transformant (95) and the transformant (81) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu, mutation of 27th Met in the α-subunit with Ile and mutation of 110th Glu in the β-subunit with Asn were newly added to the transformant (95), so that the initial reaction rate was improved by 1.53 times and thermal stability was improved by 1.76 times, as compared to those of the transformant (81).

Example 54

Construction of a Transformant (96) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (96) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (1) and (am) amino acid substitution sites as shown in Table 36, the plasmid (56) recovered from the transformant (56) described in the above Reference Example 25 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43, 46 and 57 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (96) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (96). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (96) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu, mutation of 27th Met in the α-subunit with Ile and mutation of 110th Glu in the β-subunit with Asn were newly added to the plasmid (56) of Reference Example 25. In the production of an amide compound using the thus obtained transformant (96) and the transformant (56) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu, mutation of 27th Met in the α-subunit with Ile and mutation of 110th Glu in the β-subunit with Asn were newly added to the transformant (96), so that the initial reaction rate was improved by 1.49 times and thermal stability was improved by 1.69 times, as compared to those of the transformant (56).

Example 55

Construction of a Transformant (97) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (97) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (1) and (bo) amino acid substitution sites as shown in Table 36, the plasmid (94) recovered from the transformant (94) described in the above Reference Example 39 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43, 46 and 57 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (97) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (97). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (97) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu, mutation of 27th Met in the α-subunit with Ile and mutation of 110th Glu in the β-subunit with Asn were newly added to the plasmid (94) of Reference Example 39. In the production of an amide compound using the thus obtained transformant (97) and the transformant (94) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu, mutation of 27th Met in the α-subunit with Ile and mutation of 110th Glu in the β-subunit with Asn were newly added to the transformant (97), so that the initial reaction rate was improved by 1.37 times and thermal stability was improved by 1.83 times, as compared to those of the transformant (94).

	TABLE 36
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-13th, α-27th	α-13th, α-27th
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	and β-110th	and β-110th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
95	α-13th	Ile	Leu	ATC	CTC	1.53 times	1.76 times
	α-19th	Ala	Val	GCG	GTG
	α-27th	Met	Ile	ATG	ATC
	α-71st	Arg	His	CGT	CAT
	α-126th	Phe	Tyr	TTC	TAC
	β-110th	Glu	Asn	GAG	AAC
96	α-13th	Ile	Leu	ATC	CTC	1.49 times	1.69 times
	α-27th	Met	Ile	ATG	ATC
	β-46th	Met	Lys	ATG	AAG
	β-108th	Glu	Arg	GAG	CGG
	β-110th	Glu	Asn	GAG	AAC
	β-212th	Ser	Tyr	TCC	TAC
97	α-13th	Ile	Leu	ATC	CTC	1.37 times	1.83 times
	α-27th	Met	Ile	ATG	ATC
	β-110th	Glu	Asn	GAG	AAC
	β-150th	Ala	Ser	GCG	TCG
	β-217th	Asp	Cys	GAC	TGT

Reference Example 40

Construction of a Transformant (98) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (98) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ab) amino acid substitution sites as shown in Table 37, the plasma described in Example 59 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (98) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (98).

TABLE 37
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
98	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC

Example 56

Construction of a Transformant (99) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (99) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (r) and (ab) amino acid substitution sites as shown in Table 38, the plasmid (98) recovered from the transformant (98) described in the above Reference Example 40 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43, 59 and 38 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (99) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (99). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (99) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu, mutation of 206th Pro in the β-subunit with Leu and mutation of 226th Val in the β-subunit with Ile were newly added to the plasmid (98) of Reference Example 40. In the production of an amide compound using the thus obtained transformant (99) and the transformant (98) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu, mutation of 206th Pro in the β-subunit with Leu and mutation of 226th Val in the β-subunit with Ile were newly added to the transformant (99), so that the initial reaction rate was improved by 1.85 times and thermal stability was improved by 1.36 times, as compared to those of the transformant (98).

Example 57

Construction of a Transformant (100) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (100) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (r) and (ai) amino acid substitution sites as shown in Table 38, the plasmid (82) recovered from the transformant (82) described in the above Reference Example 36 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43, 59 and 38 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (100) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (100). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (100) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu, mutation of 206th Pro in the β-subunit with Leu and mutation of 226th Val in the β-subunit with Ile were newly added to the plasmid (82) of Reference Example 36. In the production of an amide compound using the thus obtained transformant (100) and the transformant (82) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu, mutation of 206th Pro in the β-subunit with Leu and mutation of 226th Val in the β-subunit with Ile were newly added to the transformant (100), so that the initial reaction rate was improved by 1.72 times and thermal stability was improved by 1.42 times, as compared to those of the transformant (82).

Example 58

Construction of a Transformant (101) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (101) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (r) and (bh) amino acid substitution sites as shown in Table 38, the plasmid (4) recovered from the transformant (4) described in the above Reference Example 3 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 43, 59 and 38 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (101) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (101). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (101) had sequences according to the purpose in which mutation of 13th Ile in the α-subunit with Leu, mutation of 206th Pro in the β-subunit with Leu and mutation of 226th Val in the β-subunit with Ile were newly added to the plasmid (4) of Reference Example 3. In the production of an amide compound using the thus obtained transformant (101) and the transformant (4) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 13th Ile in the α-subunit with Leu, mutation of 206th Pro in the β-subunit with Leu and mutation of 226th Val in the β-subunit with Ile were newly added to the transformant (101), so that the initial reaction rate was improved by 1.65 times and thermal stability was improved by 1.29 times, as compared to those of the transformant (4).

	TABLE 38
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-13th, β-206th	α-13th, β-206th
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	and β-226th	and β-226th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
99	α-13th	Ile	Leu	ATC	CTC	1.85 times	1.36 times
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-206th	Pro	Leu	CCG	CTG
	β-226th	Val	Ile	GTC	ATC
100	α-13th	Ile	Leu	ATC	CTC	1.72 times	1.42 times
	β-10th	Thr	Asp	ACC	GAC
	β-118th	Phe	Val	TTC	GTC
	β-200th	Ala	Glu	GCC	GAG
	β-206th	Pro	Leu	CCG	CTG
	β-226th	Val	Ile	GTC	ATC
101	α-13th	Ile	Leu	ATC	CTC	1.65 times	1.29 times
	β-40th	Thr	Ile	ACG	ATT
	β-61st	Ala	Val	GCC	GTC
	β-206th	Pro	Leu	CCG	CTG
	β-226th	Val	Ile	GTC	ATC

Reference Example 41

Construction of a Transformant (102) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (102) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ac) amino acid substitution sites as shown in Table 39, the plasma described in Example 60 of Patent Document 2 was used as the template, and the ribosome binding sequence was modified according to the method described in Example 1 to prepare a plasmid (102) encoding the above nitrile hydratase variant. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (102).

TABLE 39
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
102	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT

Example 59

Construction of a Transformant (103) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (103) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (s) and (ab) amino acid substitution sites as shown in Table 40, the plasmid (98) recovered from the transformant (98) described in the above Reference Example 40 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 16, 29 and 59 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (103) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (103). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (103) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu, mutation of 4th Val in the β-subunit with Met and mutation of 206th Pro in the β-subunit with Leu were newly added to the plasmid (98) of Reference Example 40. In the production of an amide compound using the thus obtained transformant (103) and the transformant (98) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu, mutation of 4th Val in the β-subunit with Met and mutation of 206th Pro in the β-subunit with Leu were newly added to the transformant (103), so that the initial reaction rate was improved by 2.50 times and thermal stability was improved by 1.57 times, as compared to those of the transformant (98).

Example 60

Construction of a Transformant (104) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (104) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (s) and (ah) amino acid substitution sites as shown in Table 40, the plasmid (37) recovered from the transformant (37) described in the above Reference Example 18 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 16, 29 and 59 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (104) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (104). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (104) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu, mutation of 4th Val in the β-subunit with Met and mutation of 206th Pro in the β-subunit with Leu were newly added to the plasmid (37) of Reference Example 18. In the production of an amide compound using the thus obtained transformant (104) and the transformant (37) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu, mutation of 4th Val in the β-subunit with Met and mutation of 206th Pro in the β-subunit with Leu were newly added to the transformant (104), so that the initial reaction rate was improved by 1.82 times and thermal stability was improved by 1.41 times, as compared to those of the transformant (37).

Example 61

Construction of a Transformant (105) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (105) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (s) and (ac) amino acid substitution sites as shown in Table 40, the plasmid (102) recovered from the transformant (102) described in the above Reference Example 41 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 16, 29 and 59 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (105) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (105). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (105) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu, mutation of 4th Val in the β-subunit with Met and mutation of 206th Pro in the β-subunit with Leu were newly added to the plasmid (102) of Reference Example 41. In the production of an amide compound using the thus obtained transformant (105) and the transformant (102) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu, mutation of 4th Val in the β-subunit with Met and mutation of 206th Pro in the β-subunit with Leu were newly added to the transformant (105), so that the initial reaction rate was improved by 1.67 times and thermal stability was improved by 1.61 times, as compared to those of the transformant (102).

	TABLE 40
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-92nd, β-4th	α-92nd, β-4th
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	and β-206th	and β-206th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
103	α-92nd	Asp	Glu	GAC	GAG	2.50 times	1.57 times
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-4th	Val	Met	GTG	ATG
	β-206th	Pro	Leu	CCG	CTG
104	α-36th	Thr	Met	ACG	ATG	1.82 times	1.41 times
	α-92nd	Asp	Glu	GAC	GAG
	α-148th	Gly	Asp	GGC	GAC
	α-204th	Val	Arg	GTC	CGC
	β-4th	Val	Met	GTG	ATG
	β-206th	Pro	Leu	CCG	CTG
105	α-92nd	Asp	Glu	GAC	GAG	1.67 times	1.61 times
	β-4th	Val	Met	GTG	ATG
	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
	β-206th	Pro	Leu	CCG	CTG

Reference Example 42

Construction of a Transformant (106) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (106) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (az) amino acid substitution sites as shown in Table 41, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 65 and 53 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (106) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (106).

TABLE 41
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
106	α-48th	Asn	Glu	AAC	GAA
	α-146th	Arg	Gly	CGG	GGG

Example 62

Construction of a Transformant (107) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (107) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (t) and (ac) amino acid substitution sites as shown in Table 42, the plasmid (102) recovered from the transformant (102) described in the above Reference Example 41 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 24, 37 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (107) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (107). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (107) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys, mutation of 107th Pro in the β-subunit with Met and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (102) of Reference Example 41. In the production of an amide compound using the thus obtained transformant (107) and the transformant (102) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys, mutation of 107th Pro in the β-subunit with Met and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (107), so that the initial reaction rate was improved by 2.11 times and thermal stability was improved by 1.88 times, as compared to those of the transformant (102).

Example 63

Construction of a Transformant (108) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (108) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (t) and (al) amino acid substitution sites as shown in Table 42, the plasmid (70) recovered from the transformant (70) described in the above Reference Example 30 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 24, 37 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (108) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (108). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (108) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys, mutation of 107th Pro in the β-subunit with Met and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (70) of Reference Example 30. In the production of an amide compound using the thus obtained transformant (108) and the transformant (70) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys, mutation of 107th Pro in the β-subunit with Met and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (108), so that the initial reaction rate was improved by 1.98 times and thermal stability was improved by 2.34 times, as compared to those of the transformant (70).

Example 64

Construction (109) of a Transformant (109) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (109) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (t) and (az) amino acid substitution sites as shown in Table 42, the plasmid (106) recovered from the transformant (106) described in the above Reference Example 42 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 24, 37 and 60 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (109) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (109). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (109) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys, mutation of 107th Pro in the β-subunit with Met and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (106) of Reference Example 43. In the production of an amide compound using the thus obtained transformant (109) and the transformant (106) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys, mutation of 107th Pro in the β-subunit with Met and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (109), so that the initial reaction rate was improved by 2.05 times and thermal stability was improved by 1.62 times, as compared to those of the transformant (106).

	TABLE 42
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-197th, β-107th	α-197th, β-107th
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	and β-230th	and β-230th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
107	α-197th	Gly	Cys	GGC	TGC	2.11 times	1.88 times
	β-51st	Phe	Val	TTC	GTC
	β-107th	Pro	Met	CCC	ATG
	β-108th	Glu	Asp	GAG	GAT
	β-230th	Ala	Glu	GCG	GAG
108	α-197th	Gly	Cys	GGC	TGC	1.98 times	2.34 times
	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-107th	Pro	Met	CCC	ATG
	β-108th	Glu	Asp	GAG	GAT
	β-230th	Ala	Glu	GCG	GAG
109	α-48th	Asn	Glu	AAC	GAA	2.05 times	1.62 times
	α-197th	Gly	Cys	GGC	TGC
	β-107th	Pro	Met	CCC	ATG
	β-146th	Arg	Gly	CGG	GGG
	β-230th	Ala	Glu	GCG	GAG

Reference Example 43

Construction of a Transformant (110) Substituted Amino Acid Having Nitrile Hydratase Activity

In order to obtain a transformant (110) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (ba) amino acid substitution sites as shown in Table 43, introduction of site-specific mutation was performed using the mutagenesis kit described in the above Reference Example 2. The plasmid (1) expressing nitrile hydratase with the modified ribosome binding sequence described in Example 1 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 66 and 67 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (110) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (110).

TABLE 43
		Change in Amino	Change in
Trans-		Acid Sequence	Base Sequence
formant	Mutated	Before	After	Before	After
No.	Site	Substitution	Substitution	Substitution	Substitution
110	α-36th	Thr	Trp	ACG	TGG
	β-176th	Tyr	Cys	TAC	TGC

Example 65

Construction of a Transformant (111) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (111) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (u) and (aq) amino acid substitution sites as shown in Table 44, the plasmid (38) recovered from the transformant (38) described in the above Reference Example 19 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 33 and 69 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (111) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (111). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (111) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn, mutation of 230th Ala in the β-subunit with Glu and mutation of 231st Ala in the β-subunit with Val were newly added to the plasmid (38) of Reference Example 19. In the production of an amide compound using the thus obtained transformant (111) and the transformant (38) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn, mutation of 230th Ala in the β-subunit with Glu and mutation of 231st Ala in the β-subunit with Val were newly added to the transformant (111), so that the initial reaction rate was improved by 1.46 times and thermal stability was improved by 1.43 times, as compared to those of the transformant (38).

Example 66

Construction of a Transformant (112) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (112) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (u) and (ap) amino acid substitution sites as shown in Table 44, the plasmid (9) recovered from the transformant (9) described in the above Reference Example 5 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 33 and 69 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (112) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (112). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (112) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn, mutation of 230th

Ala in the β-subunit with Glu and mutation of 231st Ala in the β-subunit with Val were newly added to the plasmid (9) of Reference Example 5. In the production of an amide compound using the thus obtained transformant (112) and the transformant (9) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn, mutation of 230th Ala in the β-subunit with Glu and mutation of 231st Ala in the β-subunit with Val were newly added to the transformant (112), so that the initial reaction rate was improved by 1.42 times and thermal stability was improved by 1.66 times, as compared to those of the transformant (9).

Example 67

Construction of a Transformant (113) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (113) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (u) and (ba) amino acid substitution sites as shown in Table 44, the plasmid (110) recovered from the transformant (110) described in the above Reference Example 43 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 33 and 69 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (113) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (113). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (113) had sequences according to the purpose in which mutation of 79th His in the β-subunit with Asn, mutation of 230th Ala in the β-subunit with Glu and mutation of 231st Ala in the β-subunit with Val were newly added to the plasmid (110) of Reference Example 43. In the production of an amide compound using the thus obtained transformant (113) and the transformant (110) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 79th His in the β-subunit with Asn, mutation of 230th Ala in the β-subunit with Glu and mutation of 231st Ala in the β-subunit with Val were newly added to the transformant (113), so that the initial reaction rate was improved by 1.39 times and thermal stability was improved by 1.38 times, as compared to those of the transformant (110).

	TABLE 44
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	β-79th, β-230th	β-79th, β-230th
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	and β-231st	and β-231st
No.	Site	tion	tion	tion	tion	Substitution	Substitution
111	α-6th	Leu	Thr	CTG	ACG	1.46 times	1.43 times
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-48th	Leu	Val	CTG	GTG
	β-79th	His	Asn	CAC	AAC
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
	β-230th	Ala	Glu	GCG	GAG
	β-231st	Ala	Val	GCC	GTC
112	α-6th	Leu	Thr	CTG	ACG	1.42 times	1.66 times
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-46th	Met	Lys	ATG	AAG
	β-79th	His	Asn	CAC	AAC
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
	β-230th	Ala	Glu	GCG	GAG
	β-231st	Ala	Val	GCC	GTC
113	α-36th	Thr	Trp	ACG	TGG	1.39 times	1.38 times
	β-79th	His	Asn	CAC	AAC
	β-176th	Tyr	Cys	TAC	TGC
	β-230th	Ala	Glu	GCG	GAG
	β-231st	Ala	Val	GCC	GTC

Example 68

Construction of a Transformant (114) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (114) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (v) and (al) amino acid substitution sites as shown in Table 45, the plasmid (70) recovered from the transformant (70) described in the above Reference Example 30 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 16, 38 and 70 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (114) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (114). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (114) had sequences according to the purpose in which mutation of 92nd Asp in the α-subunit with Glu, mutation of 24th Val in the β-subunit with Ile and mutation of 226th Val in the β-subunit with Ile were newly added to the plasmid (70) of Reference Example 30. In the production of an amide compound using the thus obtained transformant (114) and the transformant (70) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 92nd Asp in the α-subunit with Glu, mutation of 24th Val in the β-subunit with Ile and mutation of 226th Val in the β-subunit with Ile were newly added to the transformant (114), so that the initial reaction rate was improved by 2.43 times and thermal stability was improved by 1.63 times, as compared to those of the transformant (70).

	TABLE 45
	Improvement of
	Change in Amino Acid	Change in Base	Improvement of	Thermal
	Sequence	Sequence	Reaction Rate by	Stability by
Trans-		Before	After	Before	After	α-92nd, β-24th	α-92nd, β-24th
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	and β-226th	and β-226th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
114	α-92nd	Asp	Glu	GAC	GAG	2.43 times	1.63 times
	β-24th	Val	Ile	GTC	ATC
	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-108th	Glu	Asp	GAG	GAT
	β-226th	Val	Ile	GTC	ATC

Example 69

Construction of a Transformant (115) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (115) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (w) and (al) amino acid substitution sites as shown in Table 46, the plasmid (70) recovered from the transformant (70) described in the above Reference Example 30 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 24, 37, 60 and 70 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (115) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (115). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (115) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys, mutation of 24th Val in the β-subunit with Ile, mutation of 107th Pro in the β-subunit with Met, and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (70) of Reference Example 30. In the production of an amide compound using the thus obtained transformant (115) and the transformant (70) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys, mutation of 24th Val in the β-subunit with Ile, mutation of 107th Pro in the β-subunit with Met, and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (115), so that the initial reaction rate was improved by 2.23 times and thermal stability was improved by 2.51 times, as compared to those of the transformant (70).

Example 70

Construction of a Transformant (116) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (116) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (w) and (az) amino acid substitution sites as shown in Table 46, the plasmid (106) recovered from the transformant (106) described in the above Reference Example 42 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 24, 37, 60 and 70 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (116) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (116). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (116) had sequences according to the purpose in which mutation of 197th Gly in the α-subunit with Cys, mutation of 24th Val in the β-subunit with Ile, mutation of 107th Pro in the β-subunit with Met, and mutation of 230th Ala in the β-subunit with Glu were newly added to the plasmid (106) of Reference Example 42. In the production of an amide compound using the thus obtained transformant (116) and the transformant (106) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 197th Gly in the α-subunit with Cys, mutation of 24th Val in the β-subunit with Ile, mutation of 107th Pro in the β-subunit with Met, and mutation of 230th Ala in the β-subunit with Glu were newly added to the transformant (116), so that the initial reaction rate was improved by 2.35 times and thermal stability was improved by 1.87 times, as compared to those of the transformant (106).

	TABLE 46
		Improvement of
	Improvement of	Thermal
	Change in Amino Acid	Change in Base	Reaction Rate by	Stability by
	Sequence	Sequence	α-197th, β-24th,	α-197th, β-24th,
Trans-		Before	After	Before	After	β-107th and	β-107th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-230th	β-230th
No.	Site	tion	tion	tion	tion	Substitution	Substitution
115	α-197th	Gly	Cys	GGC	TGC	2.23 times	2.51 times
	β-24th	Val	Ile	GTC	ATC
	β-41st	Phe	Ile	TTC	ATC
	β-51st	Phe	Val	TTC	GTC
	β-107th	Pro	Met	CCC	ATG
	β-108th	Glu	Asp	GAG	GAT
	β-230th	Ala	Glu	GCG	GAG
116	α-48th	Asn	Glu	AAC	GAA	2.35 times	1.87 times
	α-197th	Gly	Cys	GGC	TGC
	β-24th	Val	Ile	GTC	ATC
	β-107th	Pro	Met	CCC	ATG
	β-146th	Arg	Gly	CGG	GGG
	β-230th	Ala	Glu	GCG	GAG

Example 71

Construction of a Transformant (117) Substituted Amino Acid Having Improved Nitrile Hydratase Activity and Improved Thermal Stability

In order to obtain a transformant (117) expressing the nitrile hydratase variant obtained by mutating nitrile hydratase at (x) and (aq) amino acid substitution sites as shown in Table 47, the plasmid (38) recovered from the transformant (38) described in the above Reference Example 19 was used as the template, and the primers having the sequence defined in SEQ ID Nos: 33, 69 and 70 in the Sequence Listing were used for repeatedly carrying out the method described in Reference Example 2 per mutation point, whereby a plasmid (117) encoding the above nitrile hydratase variant was prepared. A competent cell of Escherichia coli HB101 (manufactured by Toyobo Co., Ltd.) was transformed with the plasmid to obtain a transformant (117). Moreover, the plasmid was prepared from the above-mentioned microbial cells by the alkaline SDS extraction method, and the base sequence of the nitrile hydratase gene was determined using a DNA sequencer. Then, it was confirmed that the transformant (117) had sequences according to the purpose in which mutation of 24th Val in the β-subunit with Ile, mutation of 79th His in the β-subunit with Asn, mutation of 230th Ala in the β-subunit with Glu, and mutation of 231st Ala in the β-subunit with Val were newly added to the plasmid (38) of Reference Example 19. In the production of an amide compound using the thus obtained transformant (117) and the transformant (38) to be its base, the initial reaction rate and thermal stability were compared in the same manner as in Example 1.

As a result, it was found that mutation of 24th Val in the β-subunit with Ile, mutation of 79th His in the β-subunit with Asn, mutation of 230th Ala in the β-subunit with Glu, and mutation of 231st Ala in the β-subunit with Val were newly added to the transformant (117), so that the initial reaction rate was improved by 1.73 times and thermal stability was improved by 1.50 times, as compared to those of the transformant (38).

	TABLE 47
		Improvement of
	Improvement of	Thermal
	Change in Amino Acid	Change in Base	Reaction Rate by	Stability by
	Sequence	Sequence	β-24th, β-79th,	β-24th, β-79th,
Trans-		Before	After	Before	After	β-230th and	β-230th and
formant	Mutated	Substitu-	Substitu-	Substitu-	Substitu-	β-231st	β-231st
No.	Site	tion	tion	tion	tion	Substitution	Substitution
117	α-6th	Leu	Thr	CTG	ACG	1.73 times	1.50 times
	α-19th	Ala	Val	GCG	GTG
	α-126th	Phe	Tyr	TTC	TAC
	β-24th	Val	Ile	GTC	ATC
	β-48th	Leu	Val	CTG	GTG
	β-79th	His	Asn	CAC	AAC
	β-108th	Glu	Arg	GAG	CGG
	β-212th	Ser	Tyr	TCC	TAC
	β-230th	Ala	Glu	GCG	GAG
	β-231st	Ala	Val	GCC	GTC

Claims

1. A nitrile hydratase variant comprising substitution of at least one amino acid with another amino acid to improve two or more properties of nitrile hydratase by substitution of 1, 2 or 3 amino acids, wherein

wherein said properties to be improved are the initial reaction rate and thermal stability, and

wherein the nitrile hydratase variant comprises an α-subunit defined in SEQ ID No: 1 in the Sequence Listing and a β-subunit defined in SEQ ID No: 2 in the Sequence Listing, and substitution of at least one amino acid with another amino acid selected from substitution sites of the amino acid consisting of the following (b) to (l):

(a) 92nd of α-subunit;

(b) 94th of α-subunit;

(c) 197th of α-subunit;

(d) 4th of β-subunit;

(e) 24th of β-subunit;

(f) 79th of β-subunit;

(g) 96th of β-subunit;

(h) 107th of β-subunit;

(i) 226th of β-subunit;

(j) 110th of β-subunit and 231st of β-subunit;

(k) 206th of β-subunit and 230th of β-subunit; and

(l) 13th of α-subunit, 27th of α-subunit and 110th of β-subunit,

Ile is substituted by Leu when 13th amino acid of the α-subunit is substituted,

Met is substituted by Ile when the 27th amino acid of the α-subunit is substituted,

Asp is substituted by Glu when the 92nd amino acid of the α-subunit is substituted,

Met is substituted by Ile when the 94th amino acid of the α-subunit is substituted,

Gly is substituted by Cys when the 197th amino acid of the α-subunit is substituted,

Val is substituted by Met when the 4th amino acid of the β-subunit is substituted,

Val is substituted by Ile when the 24th amino acid of the β-subunit is substituted,

His is substituted by Asn when the 79th amino acid of the β-subunit is substituted,

Gln is substituted by Arg when the 96th amino acid of the β-subunit is substituted,

Pro is substituted by Met when the 107th amino acid of the β-subunit is substituted,

Glu is substituted by Asn when the 110th amino acid of the β-subunit is substituted,

Pro is substituted by Leu when the 206th amino acid of the β-subunit is substituted,

Val is substituted by Ile when the 226th amino acid of the β-subunit is substituted,

Ala is substituted by Glu when the 230th amino acid of the β-subunit is substituted, and

Ala is substituted by Val when the 231st amino acid of the β-subunit is substituted.

2. The nitrile hydratase variant according to claim 1, comprising substitution of at least one amino acid with another amino acid selected from substitution sites of the amino acid consisting of the following (m) to (x):

(m) in case of (b) or (g), 13th Ile in the α-subunit is substituted by Leu;

(n) in case of (b) or (h), 27th Met in the α-subunit is substituted by Ile;

(o) (d) and (f);

(p) in case of (f), 230th Ala in the β-subunit is substituted by Glu;

(q) (a) and (i);

(r) in case of (i), 13th Ile in the α-subunit is substituted by Leu and 206th Pro in the β-subunit is substituted by Leu;

(s) in case of (a) and (d), 206th Pro in the β-subunit is substituted by Leu;

(t) in case of (c) and (h), 230th Ala in the β-subunit is substituted by Glu;

(u) in case of (f), 230th Ala in the β-subunit is substituted by Glu and 231st Ala in the β-subunit is substituted by Val;

(v) (a) and (e) and (i);

(w) in case of (c) and (e) and (h), 230th Ala in the β-subunit is substituted by Glu; and

(x) in case of (e) and (f), 230th Ala in the β-subunit is substituted by Glu and 231st Ala in the β-subunit is substituted by Val.

3. The nitrile hydratase variant according to claim 1, further comprising substitution of at least one amino acid with another amino acid selected from the group consisting of (a), (c), (f), (i), (h), 230th of the β-subunit and 231st of the β-subunit in case of (e) is substituted with another amino acid.

4. The nitrile hydratase variant according to claim 1, further comprising substitution of at least one amino acid selected from substitutions of the amino acid consisting of the following (aa) to (br):

(aa) 36th Thr in the α-subunit is substituted by Met and 126th Phe in the α-subunit is substituted by Tyr;

(ab) 148th Gly in the α-subunit is substituted by Asp and 204th Val in the α-subunit is substituted by Arg;

(ac) 51st Phe in the β-subunit is substituted by Val and 108th Glu in the β-subunit is substituted by Asp;

(ad) 118th Phe in the β-subunit is substituted by Val and 200th Ala in the β-subunit is substituted by Glu;

(ae) 160th Arg in the β-subunit is substituted by Trp and 186th Leu in the β-subunit is substituted by Arg;

(af) 6th Leu in the α-subunit is substituted by Thr, 36th Thr in the α-subunit is substituted by Met, and 126th Phe in the α-subunit is substituted by Tyr;

(ag) 19th Ala in the α-subunit is substituted by Val, 71st Arg in the α-subunit is substituted by His, and 126th Phe in the α-subunit is substituted by Tyr;

(ah) 36th Thr in the α-subunit is substituted by Met, 148th Gly in the α-subunit is substituted by Asp, and 204th Val in the α-subunit is substituted by Arg;

(ai) 10th Thr in the β-subunit is substituted by Asp, 118th Phe in the β-subunit is substituted by Val, and 200th Ala in the β-subunit is substituted by Glu;

(aj) 37th Phe in the β-subunit is substituted by Leu, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(ak) 37th Phe in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(al) 41st Phe in the β-subunit is substituted by Ile, 51st Phe in the β-subunit is substituted by Val, and 108th Glu in the β-subunit is substituted by Asp;

(am) 46th Met in the β-subunit is substituted by Lys, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(an) 48th Leu in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(ao) 127th Leu in the β-subunit is substituted by Ser, 160th Arg in the β-subunit is substituted by Trp, and 186th Leu in the β-subunit is substituted by Arg;

(ap) 6th Leu in the α-subunit is substituted by Thr, 19th Ala in the α-subunit is substituted by Val, 126th Phe in the α-subunit is substituted by Tyr, 46th Met in the β-subunit is substituted by Lys, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(aq) 6th Leu in the α-subunit is substituted by Thr, 19th Ala in the α-subunit is substituted by Val, 126th Phe in the α-subunit is substituted by Tyr, 48th Leu in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Arg, and 212th Ser in the β-subunit is substituted by Tyr;

(ar) 6th Leu in the α-subunit is substituted by Ala, 19th Ala in the α-subunit is substituted by Val, 126th Phe in the α-subunit is substituted by Tyr, 127th Leu in the β-subunit is substituted by Ser, 160th Arg in the β-subunit is substituted by Trp, and 186th Leu in the β-subunit is substituted by Arg;

(as) 6th Leu in the α-subunit is substituted by Thr, 36th Thr in the α-subunit is substituted by Met, 126th Phe in the α-subunit is substituted by Tyr, 10th Thr in the β-subunit is substituted by Asp, 118th Phe in the β-subunit is substituted by Val, and 200th Ala in the β-subunit is substituted by Glu;

(at) 19th Ala in the α-subunit is substituted by Val, 71st Arg in the α-subunit is substituted by His, 126th Phe in the α-subunit is substituted by Tyr, 37th Phe in the β-subunit is substituted by Leu, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(au) 19th Ala in the α-subunit is substituted by Val, 71st Arg in the α-subunit is substituted by His, 126th Phe in the α-subunit is substituted by Tyr, 37th Phe in the β-subunit is substituted by Val, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(av) 36th Thr in the α-subunit is substituted by Met, 148th Gly in the α-subunit is substituted by Asp, 204th Val in the α-subunit is substituted by Arg, 41st Phe in the β-subunit is substituted by Ile, 51st Phe in the β-subunit is substituted by Val, and 108th Glu in the β-subunit is substituted by Asp;

(aw) 148th Gly in the α-subunit is substituted by Asp, 204th Val in the α-subunit is substituted by Arg, 108th Glu in the β-subunit is substituted by Asp, and 200th Ala in the β-subunit is substituted by Glu;

(ax) 36th Thr in the α-subunit is substituted by Gly and 188th Thr in the α-subunit is substituted by Gly;

(ay) 36th Thr in the α-subunit is substituted by Ala and 48th Asn in the α-subunit is substituted by Gln;

(az) 48th Asn in the α-subunit is substituted by Glu and 146th Arg in the β-subunit is substituted by Gly;

(ba) 36th Thr in the α-subunit is substituted by Trp and 176th Tyr in the β-subunit is substituted by Cys;

(bb) 176th Tyr in the β-subunit is substituted by Met and 217th Asp in the β-subunit is substituted by Gly;

(bc) 36th Thr in the α-subunit is substituted by Ser, and 33rd Ala in the β-subunit is substituted by Val;

(bd) 176th Tyr in the β-subunit is substituted by Ala and 217th Asp in the β-subunit is substituted by Val;

(be) 40th Thr in the β-subunit is substituted by Val and 218th Cys in the β-subunit is substituted by Met;

(bf) 33rd Ala in the β-subunit is substituted by Met and 176th Tyr in the β-subunit is substituted by Thr;

(bg) 40th Thr in the β-subunit is substituted by Leu and 217th Asp in the β-subunit is substituted by Leu;

(bh) 40th Thr in the β-subunit is substituted by Ile and 61st Ala in the β-subunit is substituted by Val;

(bi) 61st Ala in the β-subunit is substituted by Thr and 218th Cys in the β-subunit is substituted by Ser;

(bj) 112th Lys in the β-subunit is substituted by Val and 217th Asp in the β-subunit is substituted by Met;

(bk) 61st Ala in the β-subunit is substituted by Trp and 217th Asp in the β-subunit is substituted by His;

(bl) 61st Ala in the β-subunit is substituted by Leu and 112th Lys in the β-subunit is substituted by Ile;

(bm) 146th Arg in the β-subunit is substituted by Gly and 217th Asp in the β-subunit is substituted by Ser;

(bn) 171st Lys in the β-subunit is substituted by Ala and 217th Asp in the β-subunit is substituted by Thr;

(bo) 150th Ala in the β-subunit is substituted by Ser and 217th Asp in the β-subunit is substituted by Cys;

(bp) 61st Ala in the β-subunit is substituted by Gly and 150th Ala in the β-subunit is substituted by Asn;

(bq) 61st Ala in the β-subunit is substituted by Ser and 160th Arg in the β-subunit is substituted by Met; and

(br) 160th Arg in the β-subunit is substituted by Cys and 168th Thr in the β-subunit is substituted by Glu.

5. The nitrile hydratase variant according to claim 1, comprising substitutions at the following substitution sites (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), (XI), (XII), (XIII) or (XIV) with another amino acids:

(I) 36th of α-subunit, 92nd of α-subunit, 148th of α-subunit, 204th of α-subunit, 41st of β-subunit, 51st of β-subunit and 108th of β-subunit;

(II) 6th of α-subunit, 19th of α-subunit, 94th of α-subunit, 126th of α-subunit, 46th of β-subunit, 108th of β-subunit and 212th of β-subunit;

(III) 6th of α-subunit, 19th of α-subunit, 126th of α-subunit, 4th of β-subunit, 127th of β-subunit, 160th of β-subunit and 186th of β-subunit;

(IV) 19th of α-subunit, 71st of α-subunit, 126th of α-subunit, 37th of β-subunit, 79th of β-subunit, 108th of β-subunit and 200th of β-subunit;

(V) 6th of α-subunit, 19th of α-subunit, 126th of α-subunit, 48th of β-subunit, 96th of β-subunit, 108th of β-subunit and 212th of β-subunit;

(VI) 19th of α-subunit, 71st of α-subunit, 126th of α-subunit, 37th of β-subunit, 107th of β-subunit, 108th of β-subunit and 200th of β-subunit;

(VII) 13th of α-subunit, 19th of α-subunit, 71st of α-subunit, 126th of α-subunit, 37th of β-subunit, 96th of β-subunit, 108th of β-subunit and 200th of β-subunit;

(VIII) 6th of α-subunit, 27th of α-subunit, 36th of α-subunit, 126th of α-subunit, 10th of β-subunit, 107th of β-subunit, 118th of β-subunit and 200th of β-subunit;

(IX) 6th of α-subunit, 19th of α-subunit, 126th of α-subunit, 48th of β-subunit, 79th of β-subunit, 108th of β-subunit, 212th of β-subunit and 230th of β-subunit;

(X) 6th of α-subunit, 36th of α-subunit, 126th of α-subunit, 10th of β-subunit, 118th of β-subunit, 200th of β-subunit, 206th of β-subunit and 230th of β-subunit;

(XI) 36th of α-subunit, 148th of α-subunit, 204th of α-subunit, 41st of β-subunit, 51st of β-subunit, 108th of β-subunit, 206th of β-subunit and 230th of β-subunit;

(XII) 6th of α-subunit, 19th of α-subunit, 126th of α-subunit, 48th of β-subunit, 79th of β-subunit, 108th of β-subunit, 212th of β-subunit, 230th of β-subunit and 231st of β-subunit;

(XIII) 6th of α-subunit, 19th of α-subunit, 126th of α-subunit, 46th of β-subunit, 79th of β-subunit, 108th of β-subunit, 212th of β-subunit, 230th of β-subunit and 231st of β-subunit;

(XIV) 6th of α-subunit, 19th of α-subunit, 126th of α-subunit, 24th of β-subunit, 48th of β-subunit, 79th of β-subunit, 108th of β-subunit, 212th of β-subunit, 230th of β-subunit and 231st of β-subunit.

6. The nitrile hydratase variant according to claim 5, wherein:

in case of (I), 36th of α-subunit is substituted with Met, 92nd of α-subunit is substituted with Glu, 148th of α-subunit is substituted with Asp, 204th of α-subunit is substituted with Arg, 41st of β-subunit is substituted with Ile, 51st of β-subunit is substituted with Val, and 108th of β-subunit is substituted with Asp;

in case of (II), 6th of α-subunit is substituted with Thr, 19th of α-subunit is substituted with Val, 94th of α-subunit is substituted with Ile, 126th of α-subunit is substituted with Tyr, 46th of β-subunit is substituted with Lys, 108th of β-subunit is substituted with Arg, and 212th of β-subunit is substituted with Tyr;

in case of (III), 6th of α-subunit is substituted with Ala, 19th of α-subunit is substituted with Val, 126th of α-subunit is substituted with Tyr, 4th of β-subunit is substituted with Met, 127th of β-subunit is substituted with Ser, 160th of β-subunit is substituted with Trp, and 186th of β-subunit is substituted with Arg;

in case of (IV), 19th of α-subunit is substituted with Val, 71st of α-subunit is substituted with His, 126th of α-subunit is substituted with Tyr, 37th of β-subunit is substituted with Val, 79th of β-subunit is substituted with Asn, 108th of β-subunit is substituted with Asp, and 200th of β-subunit is substituted with Glu;

in case of (V), 6th of α-subunit is substituted with Thr, 19th of α-subunit is substituted with Val, 126th of α-subunit is substituted with Tyr, 48th of β-subunit is substituted with Val, 96th of β-subunit is substituted with Arg, 108th of β-subunit is substituted with Arg, and 212th of β-subunit is substituted with Tyr;

in case of (VI), 19th of α-subunit is substituted with Val, 71st of α-subunit is substituted with His, 126th of α-subunit is substituted with Tyr, 37th of β-subunit is substituted with Val, 107th of β-subunit is substituted with Met, 108th of β-subunit is substituted with Asp, and 200th of β-subunit is substituted with Glu;

in case of (VII), 13th of α-subunit is substituted with Leu, 19th of α-subunit is substituted with Val, 71st of α-subunit is substituted with His, 126th of α-subunit is substituted with Tyr, 37th of β-subunit is substituted with Leu, 96th of β-subunit is substituted with Arg, 108th of β-subunit is substituted with Asp, and 200th of β-subunit is substituted with Glu;

in case of (VIII), 6th of α-subunit is substituted with Thr, 27th of α-subunit is substituted with Ile, 36th of α-subunit is substituted with Met, 126th of α-subunit is substituted with Tyr, 10th of β-subunit is substituted with Asp, 107th of β-subunit is substituted with Met, 118th of β-subunit is substituted with Val, and 200th of β-subunit is substituted with Glu;

in case of (IX), 6th of α-subunit is substituted with Thr, 19th of α-subunit is substituted with Val, 126th of α-subunit is substituted with Tyr, 48th of β-subunit is substituted with Val, 79th of β-subunit is substituted with Asn, 108th of β-subunit is substituted with Arg, 212th of β-subunit is substituted with Tyr, and 230th of β-subunit is substituted with Glu;

in case of (X), 6th of α-subunit is substituted with Thr, 36th of α-subunit is substituted with Met, 126th of α-subunit is substituted with Tyr, 10th of β-subunit is substituted with Asp, 118th of β-subunit is substituted with Val, 200th of β-subunit is substituted with Glu, 206th of β-subunit is substituted with Leu, and 230th of β-subunit is substituted with Glu;

in case of (XI), 36th of α-subunit is substituted with Met, 148th of α-subunit is substituted with Asp, 204th of α-subunit is substituted with Arg, 41st of β-subunit is substituted with Ile, 51st of β-subunit is substituted with Val, 108th of β-subunit is substituted with Asp, 206th of β-subunit is substituted with Leu, and 230th of β-subunit is substituted with Glu;

in case of (XII), 6th of α-subunit is substituted with Thr, 19th of α-subunit is substituted with Val, 126th of α-subunit is substituted with Tyr, 48th of β-subunit is substituted with Val, 79th of β-subunit is substituted with Asn, 108th of β-subunit is substituted with Arg, 212th of β-subunit is substituted with Tyr, 230th of β-subunit is substituted with Glu, and 231st of β-subunit is substituted with Val;

in case of (XIII), 6th of α-subunit is substituted with Thr, 19th of α-subunit is substituted with Val, 126th of α-subunit is substituted with Tyr, 46th of β-subunit is substituted with Lys, 79th of β-subunit is substituted with Asn, 108th of β-subunit is substituted with Arg, 212th of β-subunit is substituted with Tyr, 230th of β-subunit is substituted with Glu, and 231st of β-subunit is substituted with Val;

in case of (XIV), 6th of α-subunit is substituted with Thr, 19th of α-subunit is substituted with Val, 126th of α-subunit is substituted with Tyr, 24th of β-subunit is substituted with Ile, 48th of β-subunit is substituted with Val, 79th of β-subunit is substituted with Asn, 108th of β-subunit is substituted with Arg, 212th of β-subunit is substituted with Tyr, 230th of β-subunit is substituted with Glu, and 231st of β-subunit is substituted with Val.

7. A gene encoding the nitrile hydratase variant according to claim 1.

8. A gene encoding a nitrile hydratase variant having a gene encoding the α-subunit defined in SEQ ID No: 3 in the Sequence Listing and a gene encoding the β-subunit defined in SEQ ID No: 4 in the Sequence Listing, comprising substitution of at least one base selected from substitution sites of the base consisting of the following (b) to (l):

(a) 274th to 276th of the base sequence of SEQ ID No: 3;

(b) 280th to 282nd of the base sequence of SEQ ID No: 3;

(c) 589th to 591st of the base sequence of SEQ ID No: 3;

(d) 10th to 12th of the base sequence of SEQ ID No: 4;

(e) 70th to 72st of the base sequence of SEQ ID No: 4;

(f) 235th to 237th of the base sequence of SEQ ID No: 4;

(g) 286th to 288th of the base sequence of SEQ ID No: 4;

(h) 319th to 321st of the base sequence of SEQ ID No: 4;

(i) 676th to 678th of the base sequence of SEQ ID No: 4;

(j) 328th to 330th of the base sequence of SEQ ID No: 4 and 691st to 693rd of the base sequence of SEQ ID No: 4;

(k) 616th to 618th of the base sequence of SEQ ID No: 4, and 688th to 690th of the base sequence of SEQ ID No: 4; and

(l) 37th to 39th of the base sequence of SEQ ID No: 3, 79th to 81st of the base sequence of SEQ ID No: 3, and 328th to 330th of the base sequence of SEQ ID No: 4,

wherein ATC is substituted by CTC when 37th to 39th of the base sequence of SEQ ID No: 3 are substituted by another base,

ATG is substituted by ATC when 79th to 81th of the base sequence of SEQ ID No: 3 are substituted by another base,

GAC is substituted by GAG when 274th to 276th of the base sequence of SEQ ID No: 3 are substituted by another base,

ATG is substituted by ATC when 280th to 282th of the base sequence of SEQ ID No: 3 are substituted by another base,

GGC is substituted by TGC when 589th to 591th of the base sequence of SEQ ID No: 3 are substituted by another base,

GTG is substituted by ATG when 10th to 12th of the base sequence of SEQ ID No: 4 are substituted by another base,

GTC is substituted by ATC when 70th to 72st of the base sequence of SEQ ID No: 4 are substituted by another base,

CAC is substituted by AAC when 235th to 237th of the base sequence of SEQ ID No: 4 are substituted by another base,

CAG is substituted by CGT when 286th to 288th of the base sequence of SEQ ID No: 4 are substituted by another base,

CCC is substituted by ATG when 319th to 321st of the base sequence of SEQ ID No: 4 are substituted by another base,

GAG is substituted by AAC when 328th to 330th of the base sequence of SEQ ID No: 4 are substituted by another base,

CCG is substituted by CTG when 616th to 618th of the base sequence of SEQ ID No: 4 are substituted by another base,

GTC is substituted by ATC when 676th to 678th of the base sequence of SEQ ID No: 4 are substituted by another base,

GCG is substituted by GAG when 688th to 690th of the base sequence of SEQ ID No: 4 are substituted by another base, and

GCC is substituted by GTC when 691th to 693th of the base sequence of SEQ ID No: 4 are substituted by another base.

9. The gene encoding a nitrile hydratase variant according to claim 8, further comprising substitution of at least one base selected from substitution sites of the base consisting of the following (m) to (x):

(m) in case of (b) or (g), 37th to 39th ATC of the base sequence of SEQ ID No: 3 are substituted by CTC;

(n) in case of (b) or (h), 79th to 81st ATG of the base sequence of SEQ ID No: 3 are substituted by ATC;

(o) (d) and (f);

(p) in case of (f), 688th to 690th GCG of the base sequence of SEQ ID No: 4 are substituted by GAG;

(q) (a) and (i);

(r) in case of (i), 37th to 39th ATC of the base sequence of SEQ ID No: 3 are substituted by CTC and 616th to 618th CCG of the base sequence of SEQ ID No: 4 are substituted by CTG;

(s) in case of (a) and (d), 616th to 618th CCG of the base sequence of SEQ ID No: 4 are substituted by CTG;

(t) in case of (c) and (h), 688th to 690th GCG of the base sequence of SEQ ID No: 4 are substituted by GAG;

(u) in case of (f), 688th to 690th GCG of the base sequence of SEQ ID No: 4 are substituted by GAG and 691st to 693rd GCC of the base sequence of SEQ ID No: 4 are substituted by GTC;

(v) (a) and (e) and (i);

(w) in case of (c) and (e) and (h), 688th to 690th GCG of the base sequence of SEQ ID No: 4 are substituted by GAG; and

(x) in case of (e) and (f), 688th to 690th GCG of the base sequence of SEQ ID No: 4 are substituted by GAG and 691st to 693rd GCC of the base sequence of SEQ ID No: 4 are substituted by GTC.

10. The gene encoding a nitrile hydratase variant according to claim 8, further comprising substitution of at least one base with another base selected from substitution sites of the base consisting of (a), (c), (f), (i), (h), 688th to 690th of the base sequence of SEQ ID No: 4, and 691st to 693rd of the base sequence of SEQ ID No: 4, in case of (e), are substituted with another base.

11. The gene encoding a nitrile hydratase variant according to claim 8, comprising substitution of at least one base selected from substitution sites of the base consisting of the following (aa) to (br):

(aa) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, and 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC;

(ab) 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, and 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC;

(ac) 151st to 153rd TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT;

(ad) 352nd to 354th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(ae) 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGG, and 556th to 558th CTG of the base sequence of SEQ ID No: 4 are substituted by CGG;

(af) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, and 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC;

(ag) 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 211th to 213th CGT of the base sequence of SEQ ID No: 3 are substituted by CAT, and 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC;

(ah) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, and 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC;

(ai) 28th to 30th ACC of the base sequence of SEQ ID No: 4 are substituted by GAC, 352nd to 354th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(aj) 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by CTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(ak) 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(al) 121st to 123rd TTC of the base sequence of SEQ ID No: 4 are substituted by ATC, 151st to 153rd TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT;

(am) 136th to 138th ATG of the base sequence of SEQ ID No: 4 are substituted by AAG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(an) 142nd to 144th CTG of the base sequence of SEQ ID No: 4 are substituted by GTG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(ao) 379th to 381st CTG of the base sequence of SEQ ID No: 4 are substituted by TCG, 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGG, and 556th to 558th CTG of the base sequence of SEQ ID No: 4 are substituted by CGG;

(ap) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 136th to 138th ATG of the base sequence of SEQ ID No: 4 are substituted by AAG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(aq) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 142nd to 144th CTG of the base sequence of SEQ ID No: 4 are substituted by GTG, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by CGG, and 634th to 636th TCC of the base sequence of SEQ ID No: 4 are substituted by TAC;

(ar) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by GCG, 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 379th to 381st CTG of the base sequence of SEQ ID No: 4 are substituted by TCG, 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGG, and 556th to 558th CTG of the base sequence of SEQ ID No: 4 are substituted by CGG;

(as) 16th to 18th CTG of the base sequence of SEQ ID No: 3 are substituted by ACG, 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 28th to 30th ACC of the base sequence of SEQ ID No: 4 are substituted by GAC, 352nd to 354th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(at) 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 211th to 213th CGT of the base sequence of SEQ ID No: 3 are substituted by CAT, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by CTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(au) 55th to 57th GCG of the base sequence of SEQ ID No: 3 are substituted by GTG, 211th to 213th CGT of the base sequence of SEQ ID No: 3 are substituted by CAT, 376th to 378th TTC of the base sequence of SEQ ID No: 3 are substituted by TAC, 109th to 111th TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(av) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by ATG, 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC, 121st to 123rd TTC of the base sequence of SEQ ID No: 4 are substituted by ATC, 151st to 153rd TTC of the base sequence of SEQ ID No: 4 are substituted by GTC, and 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT;

(aw) 442nd to 444th GGC of the base sequence of SEQ ID No: 3 are substituted by GAC, 610th to 612th GTC of the base sequence of SEQ ID No: 3 are substituted by CGC, 322nd to 324th GAG of the base sequence of SEQ ID No: 4 are substituted by GAT, and 598th to 600th GCC of the base sequence of SEQ ID No: 4 are substituted by GAG;

(ax) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by GGG, and 562nd to 564th ACC of the base sequence of SEQ ID No: 3 are substituted by GGC;

(ay) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by GCG, and 142nd to 144th AAC of the base sequence of SEQ ID No: 3 are substituted by CAA;

(az) 142nd to 144th AAC of the base sequence of SEQ ID No: 3 are substituted by GAA, and 436th to 438th CGG of the base sequence of SEQ ID No: 4 are substituted by GGG;

(ba) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by TGG, and 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by TGC;

(bb) 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by ATG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by GGC;

(bc) 106th to 108th ACG of the base sequence of SEQ ID No: 3 are substituted by TCG, and 97th to 99th GCG of the base sequence of SEQ ID No: 4 are substituted by GTG;

(bd) 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by GCC, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by GTC;

(be) 118th to 120th ACG of the base sequence of SEQ ID No: 4 are substituted by GTG, and 652nd to 654th TGC of the base sequence of SEQ ID No: 4 are substituted by ATG;

(bf) 97th to 99th GCG of the base sequence of SEQ ID No: 4 are substituted by ATG, and 526th to 528th TAC of the base sequence of SEQ ID No: 4 are substituted by ACC;

(bg) 118th to 120th ACG of the base sequence of SEQ ID No: 4 are substituted by CTG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by CTC;

(bh) 118th to 120th ACG of the base sequence of SEQ ID No: 4 are substituted by ATT, and 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by GTC;

(bi) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by ACG, and 652nd to 654th TGC of the base sequence of SEQ ID No: 4 are substituted by TCC;

(bj) 334th to 336th AAG of the base sequence of SEQ ID No: 4 are substituted by GTG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by ATG;

(bk) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by TGG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by CAC;

(bl) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by CTC, and 334th to 336th AAG of the base sequence of SEQ ID No: 4 are substituted by ATT;

(bm) 436th to 438th CGG of the base sequence of SEQ ID No: 4 are substituted by GGG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by AGC;

(bn) 511th to 513th AAG of the base sequence of SEQ ID No: 4 are substituted by GCG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by ACC;

(bo) 448th to 450th GCG of the base sequence of SEQ ID No: 4 are substituted by TCG, and 649th to 651st GAC of the base sequence of SEQ ID No: 4 are substituted by TGT;

(bp) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by GGC, and 448th to 450th GCG of the base sequence of SEQ ID No: 4 are substituted by AAT;

(bq) 181st to 183rd GCC of the base sequence of SEQ ID No: 4 are substituted by TCG, and 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by ATG; and

(br) 478th to 480th CGG of the base sequence of SEQ ID No: 4 are substituted by TGT, and 502nd to 504th ACG of the base sequence of SEQ ID No: 4 are substituted by GAG.

12. The gene encoding a nitrile hydratase variant according to claim 8, comprising substitutions of the following (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), (XI), (XII), (XIII) or (XIV):

(I) the base sequences of 106th to 108th, 274th to 276th, 442nd to 444th and 610th to 612th in SEQ ID No: 3, and the base sequences of 121st to 123rd, 151st to 153rd, and 322nd to 324th in SEQ ID No: 4;

(II) the base sequences of 16th to 18th, 55th to 57th, 280th to 282nd and 376th to 378th in SEQ ID No: 3, and the base sequences of 136th to 138th, 322nd to 324th and 634th to 636th in SEQ ID No: 4;

(III) the base sequences of 16th to 18th, 55th to 57th, and 376th to 378th in SEQ ID No: 3, and the base sequences of 10th to 12th, 379th to 381st, 478th to 480th and 556th to 558th in SEQ ID No: 4;

(IV) the base sequences of 55th to 57th, 211th to 213th and 376th to 378th in SEQ ID No: 3, and the base sequences of 109th to 111th, 235th to 237th, 322nd to 324th and 598th to 600th in SEQ ID No: 4;

(V) the base sequences of 16th to 18th, 55th to 57th, and 376th to 378th in SEQ ID No: 3, and the base sequences of 142nd to 144th, 286th to 288th, 322nd to 324th and 634th to 636th in SEQ ID No: 4;

(VI) the base sequences of 55th to 57th, 211th to 213th, and 376th to 378th in SEQ ID No: 3, and the base sequences of 109th to 111th, 319th to 321st, 322nd to 324th and 598th to 600th in SEQ ID No: 4;

(VII) the base sequences of 37th to 39th, 55th to 57th, 211th to 213th and 376th to 378th in SEQ ID No: 3, and the base sequences of 109th to 111th, 286th to 288th, 322nd to 324th and 598th to 600th in SEQ ID No: 4;

(VIII) the base sequences of 16th to 18th, 79th to 81st, 106th to 108th and 376th to 378th in SEQ ID No: 3, and the base sequences of 28th to 30th, 319th to 321st, 352nd to 354th and 598th to 600th in SEQ ID No: 4;

(IX) the base sequences of 16th to 18th, 55th to 57th and 376th to 378th in SEQ ID No: 3, and the base sequences of 142nd to 144th, 235th to 237th, 322nd to 324th, 634th to 636th and 688th to 690th in SEQ ID No: 4;

(X) the base sequences of 16th to 18th, 106th to 108th and 376th to 378th in SEQ ID No: 3, and the base sequences of 28th to 30th, 352nd to 354th, 598th to 600th, 616th to 618th and 688th to 690th in SEQ ID No: 4;

(XI) the base sequences of 106th to 108th, 422nd to 444th and 610th to 612th in SEQ ID No: 3, and the base sequences of 121st to 123rd, 151st to 153rd, 322nd to 324th, 616th to 618th and 688th to 690th in SEQ ID No: 4;

(XII) the base sequences of 16th to 18th, 55th to 57th and 376th to 378th in SEQ ID No: 3, and the base sequences of 142nd to 144th, 235th to 237th, 322nd to 324th, 634th to 636th, 688th to 690th and 691st to 693rd in SEQ ID No: 4;

(XIII) the base sequences of 16th to 18th, 55th to 57th and 376th to 378th in SEQ ID No: 3, and the base sequences of 136th to 138th, 235th to 237th, 322nd to 324th, 634th to 636th, 688th to 690th and 691st to 693rd in SEQ ID No: 4;

(XIV) the base sequences of 16th to 18th, 55th to 57th and 376th to 378th in SEQ ID No: 3, and the base sequences of 70th to 72st, 142nd to 148th, 235th to 237th, 322nd to 324th, 634th to 636th, 688th to 690th and 691st to 693rd in SEQ ID No: 4;

13. The gene encoding a nitrile hydratase variant according to claim 12,

wherein in case of substitutions of (I):

106th to 108th of the base sequence of SEQ ID No: 3 are substituted by ATG;

274th to 276th of the base sequence of SEQ ID No: 3 are substituted by GAG;

442nd to 444th of the base sequence of SEQ ID No: 3 are substituted by GAC;

610th to 612th of the base sequence of SEQ ID No: 3 are substituted by CGC;

121st to 123rd of the base sequence of SEQ ID No: 4 are substituted by ATC;

151st to 153rd of the base sequence of SEQ ID No: 4 are substituted by GTC; and

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by GAT;

wherein in case of substitutions of (II):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

280th to 282nd of the base sequence of SEQ ID No: 3 are substituted by ATC;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

136th to 138th of the base sequence of SEQ ID No: 4 are substituted by AAG;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by CGG; and

634th to 636th of the base sequence of SEQ ID No: 4 are substituted by TAC;

wherein in case of substitutions of (III):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by GCG;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

10th to 12th of the base sequence of SEQ ID No: 4 are substituted by ATG;

379th to 381st of the base sequence of SEQ ID No: 4 are substituted by TCG;

478th to 480th of the base sequence of SEQ ID No: 4 are substituted by TGG; and

556th to 558th of the base sequence of SEQ ID No: 4 are substituted by CGG;

wherein in case of substitutions of (IV):

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

211th to 213th of the base sequence of SEQ ID No: 3 are substituted by CAT;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

109th to 111th of the base sequence of SEQ ID No: 4 are substituted by GTC;

235th to 237th of the base sequence of SEQ ID No: 4 are substituted by AAC;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by GAT; and

598th to 600th of the base sequence of SEQ ID No: 4 are substituted by GAG;

wherein in case of substitutions of (V):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

142nd to 144th of the base sequence of SEQ ID No: 4 are substituted by GTG;

286th to 288th of the base sequence of SEQ ID No: 4 are substituted by CGT;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by CGG; and

634th to 636th of the base sequence of SEQ ID No: 4 are substituted by TAC;

wherein in case of substitutions of (VI):

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

211th to 213th of the base sequence of SEQ ID No: 3 are substituted by CAT;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

109th to 111th of the base sequence of SEQ ID No: 4 are substituted by GTC;

319th to 321st of the base sequence of SEQ ID No: 4 are substituted by ATG;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by GAT; and

598th to 600th of the base sequence of SEQ ID No: 4 are substituted by GAG;

wherein in case of substitutions of (VII):

37th to 39th of the base sequence of SEQ ID No: 3 are substituted by CTC;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

211th to 213th of the base sequence of SEQ ID No: 3 are substituted by CAT;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

109th to 111th of the base sequence of SEQ ID No: 4 are substituted by CTC;

286th to 288th of the base sequence of SEQ ID No: 4 are substituted by CGT;

322th to 324th of the base sequence of SEQ ID No: 4 are substituted by GAT; and

598th to 600th of the base sequence of SEQ ID No: 4 are substituted by GAG;

wherein in case of substitutions of (VIII):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

79th to 81st of the base sequence of SEQ ID No: 3 are substituted by ATC;

106th to 108th of the base sequence of SEQ ID No: 3 are substituted by ATG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

28th to 30th of the base sequence of SEQ ID No: 4 are substituted by GAC;

319th to 321st of the base sequence of SEQ ID No: 4 are substituted by ATG;

352nd to 354th of the base sequence of SEQ ID No: 4 are substituted by GTC; and

598th to 600th of the base sequence of SEQ ID No: 4 are substituted by GAG;

wherein in case of substitutions of (IX):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

142nd to 144th of the base sequence of SEQ ID No: 4 are substituted by GTG;

235th to 237th of the base sequence of SEQ ID No: 4 are substituted by AAC;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by CGG;

634th to 636th of the base sequence of SEQ ID No: 4 are substituted by TAC; and

688th to 690th of the base sequence of SEQ ID No: 4 are substituted by GAG;

wherein in case of substitutions of (X):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

106th to 108th of the base sequence of SEQ ID No: 3 are substituted by ATG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

28th to 30th of the base sequence of SEQ ID No: 4 are substituted by GAC;

352nd to 354th of the base sequence of SEQ ID No: 4 are substituted by GTC;

598th to 600th of the base sequence of SEQ ID No: 4 are substituted by GAG;

616th to 618th of the base sequence of SEQ ID No: 4 are substituted by CTG; and

688th to 690th of the base sequence of SEQ ID No: 4 are substituted by GAG;

wherein in case of substitutions of (XI):

106th to 108th of the base sequence of SEQ ID No: 3 are substituted by ATG;

442nd to 444th of the base sequence of SEQ ID No: 3 are substituted by GAC;

610th to 612th of the base sequence of SEQ ID No: 3 are substituted by CGC;

121st to 123rd of the base sequence of SEQ ID No: 4 are substituted by ATC;

151st to 153rd of the base sequence of SEQ ID No: 4 are substituted by GTC;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by GAT;

616th to 618th of the base sequence of SEQ ID No: 4 are substituted by CTG; and

688th to 690th of the base sequence of SEQ ID No: 4 are substituted by GAG;

wherein in case of substitutions of (XII):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

142nd to 144th of the base sequence of SEQ ID No: 4 are substituted by GTG;

235th to 237th of the base sequence of SEQ ID No: 4 are substituted by AAC;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by CGG;

634th to 636th of the base sequence of SEQ ID No: 4 are substituted by TAC;

688th to 690th of the base sequence of SEQ ID No: 4 are substituted by GAG; and

691st to 693rd of the base sequence of SEQ ID No: 4 are substituted by GTC;

wherein in case of substitutions of (XIII):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

136th to 138th of the base sequence of SEQ ID No: 4 are substituted by AAG;

235th to 237th of the base sequence of SEQ ID No: 4 are substituted by AAC;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by CGG;

634th to 636th of the base sequence of SEQ ID No: 4 are substituted by TAC;

688th to 690th of the base sequence of SEQ ID No: 4 are substituted by GAG; and

691st to 693rd of the base sequence of SEQ ID No: 4 are substituted by GTC;

wherein in case of substitutions of (XIV):

16th to 18th of the base sequence of SEQ ID No: 3 are substituted by ACG;

55th to 57th of the base sequence of SEQ ID No: 3 are substituted by GTG;

376th to 378th of the base sequence of SEQ ID No: 3 are substituted by TAC;

70th to 72st of the base sequence of SEQ ID No: 4 are substituted by ATC;

142nd to 148th of the base sequence of SEQ ID No: 4 are substituted by GTG;

235th to 237th of the base sequence of SEQ ID No: 4 are substituted by AAC;

322nd to 324th of the base sequence of SEQ ID No: 4 are substituted by CGG;

634th to 636th of the base sequence of SEQ ID No: 4 are substituted by TAC;

688th to 690th of the base sequence of SEQ ID No: 4 are substituted by GAG; and

691st to 693rd of the base sequence of SEQ ID No: 4 are substituted by GTC.

14. A linked DNA comprising further DNA containing a promoter sequence necessary for the expression of the gene in the upstream region of the 5′-terminal of the gene encoding a nitrile hydratase variant according to claim 8, and a ribosome binding sequence contained in SEQ ID No: 7 in the downstream region of the 3′-terminal of the promoter.

15. A plasmid comprising the DNA according to claim 14.

16. A transformant obtained by transformation of a host cell using the plasmid according to claim 15.

17. A method for producing a nitrile hydratase variant, comprising cultivating the transformant according to claim 16 in a culture medium and producing a nitrile hydratase variant based on the nitrile hydratase gene carried by the plasmid in the transformant.